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Abstract 
Self-assembly of amphiphilic block copolymers in aqueous solution is one of the most 
important nanotechnological methods to prepare nanocarriers for different applications. 
Synthesis of new types of amphiphilic block copolymers with novel functionality and detailed 
characterization of self-assembly, influenced by self-assembly methods and different other 
parameters (molecular weight, hydrophilic to hydrophobic ratio), are important.  
 
In this thesis, I present the influence of different parameters on the self-assembly 
nanostructures for the poly(dimethylsiloxane)-block-poly(2-methyl-2-oxazoline) (PDMS-b-
PMOXA) amphiphilic block copolymers. In addition, in order to develop more functional 
amphiphilic block copolymers, another two types of copolymers, grafted poly(2-methyl-2-
oxazoline)-graft(ss)-poly(ε-caprolactone) (PMOXA-graft(ss)-PCL) and linear poly(2-ethyl-2-
oxazoline)-block-poly(ε-caprolactone)-ss-poly(L-lysine) (PEtOXA-b-PCL-ss-PLL), were 
designed and synthesized with reduction responsiveness, utilizing different polymerization 
techniques. The primary evaluation of these two new type amphiphilic block copolymers 
demonstrated that they are promising candidates as smart nanocarries for the application of 
drug delivery. 
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1. Introduction  
1.1. Amphiphilic block copolymers (ABPs) synthesis techniques 
1.1.1. Living polymerization 
Living polymerization was first described by Szwarc in 1956, and represents one of the 
ultimate goals of synthetic polymer chemists. This requires that the number of produced 
polymer chains is equal to the number of initiator groups. Therefore, the polymerization will 
proceed until all monomers have been consumed and the polymer chain ends will remain 
active, such that further addition of monomers leads to continued polymerization.1 Two key 
criteria are used to elucidate the “living” nature of a polymerization: i) the rate of initiation 
must exceed the rate of propagation, ii) no presence of termination caused by any reaction. 
The propagating species undergoes polymerization until full monomer conversion and then 
can continue to initiate the polymerization upon addition of more monomers.2  
Because of the development of living polymerization, synthetic polymer chemists are now 
able to synthesize a wide variety of polymers with precise architectures that were previous 
inaccessible using non-living polymerization techniques. Generally, the living polymerization 
includes living ionic polymerization (living anionic or cationic polymerization) and living 
radical polymerization, depending on the property of the propagating center.  
1.1.2. Living ionic (anionic and cationic) polymerization 
ABPs with defined molecular structure and narrow polydispersity indexes (PDI) can be 
synthesized through living anionic and cationic polymerization techniques.3 The main 
difference between anionic and cationic polymerization is the nature of the chain 
propagating center. If the propagating center is an anion, the polymerization is named 
anionic polymerization. Conversely, if the center is cationic, it is referred as cationic 
polymerization. For vinyl and acrylic monomers, the inductive and resonance characteristics 
of substituents decide if the monomers undergo cationic or anionic polymerization. For 
example, poly(styrene),4 poly(methacrylate), and poly(methacrylamide)5 can be synthesized 
through anionic polymerization while, poly(1, 3-dienes), poly(styrene), poly(N-vinyl carbazole) 
can be synthesized through cationic polymerization.6 Comparing cationic and anionic 
polymerizations, anionic polymerization requires stricter polymerization conditions. For 
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example, high solvent purity and water- and oxygen-free polymerization conditions are 
required. ABPs can be synthesized in a controlled fashion to achieve PDIs of 1.2 using the 
living ionic polymerization technique.7 Tomoya Higashihara et al. applied the anionic 
polymerization to synthesize ABPs, such as poly(4-vinyltriphenylamine)-block-poly(methyl 
methacrylate) (PVTPA-b-PMMA) and poly(styrene)-block-poly(4-vinyltriphenylamine)-block-
poly(styrene) (PS-b-PVTPA-b-PS) with initiator sec-butyllithium. They synthesized ABPs with 
PDIs lower than 1.1. Also, not just vinyl and acrylic monomers can undergo anionic and 
cationic polymerization, but also some of the heterocyclic monomers, such as cyclic ethers, 
acetals and amides. In section of 1.1.3., anionic and cationic ring-opening polymerization will 
be thoroughly discussed.  
1.1.3. Ring-opening polymerization (ROP)  
Besides vinyl and acrylic monomers, monomers with heterocyclic structure can be 
polymerized by living polymerization, namely living ROP. Heterocyclic monomers, which are 
usually employed for the synthesis of various hydrophobic polymers, are ε-caprolactone (ε-
CL),8 glycolide,9 D,L-lactide,10 β-butyrolactone,11 phosphoester12. The polymerization can be 
catalyzed by metal-alkoxides,13 enzymes14 and organic catalysts15. The typical polymerization 
mechanism catalyzed by metal-alkoxides for example Tin(II) 2-ethylhexanoate), is described 
in scheme 1. Most polymers synthesized from the above mentioned monomers are 
biocompatible and biodegradable.  
Sn(Oct)2
   +   R-OH 
   +
C-O
O
R'
C-O
O
R'
(Oct)2Sn O R
H
ROP
(Oct)2Sn O C
O
OR
H
R'a)
b) Sn(Cct)2
     +     R-OH OctSn-OR 
    +    OctH
OctSn-OR 
     +
C-O
O
R'
OctSn-OH R' COR
O
ROP
 
Scheme 1. The main ROP mechanism proposals with Sn(Oct)2 as a catalyst, a) complexation 
of a monomer and alcohol prior to ROP and b) formation of a tin-alkoxide before ROP of 
heterocyclic structure monomer.16  
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Heterocyclic monomers, ethylene oxide and 2-methyl-2-oxazoline can also undergo ROP in 
order to obtain hydrophilic polymers, as poly(ethylene oxide) (PEO) and poly(2-methyl-2-
oxazoline) (PMOXA). PEO and PMOXA can be synthesized by either anionic or cationic ROP. 
For example, PMOXA can be synthesized from 2-methyl-2-oxazoline through cationic ROP 
initiated by methyl trifluoromethanesulfonate in scheme 2.17,18 Both PMOXA and PEO have 
high resistance to protein absorption and bacteria adhesion; therefore ABPs containing 
PMOXA and PEO blocks are especially designed and synthesized for medical applications.19  
Me-G
ON
N
G
O ON
N
O
ON
G
N
Nuc
O
n n+1
Nuc
1 2 3
G = counter-ion (typically tosylate or triflate)
Nuc = nucleophilic terminating group  
Scheme 2. Synthetic procedure of PMOXA through cationic ROP. 
 
Interestingly, α-Amino Acid N-Carboxyanhydride (NCA) initiated by a primary or secondary 
amine through ROP can be applied to synthesize homopolypeptides.20 However, the 
mechanism of ROP with NCA is not ionic polymerization. Homopolypeptides are a kind of 
advanced evolution biopolymers with striking secondary structures and with adjustable 
hydrophobicity and hydrophilicity controlled by selecting the suitable NCA (mechanism 
shown in Scheme 3).20,21 By choosing the appropriate NCA, polymers containing domains 
comprised of structural and functional elements similar to those found within natural 
proteins (for example, α-helices, β-sheets, and containing desired polar and hydrophobic 
regions) can be obtained. It is quite challenging to control the structure of synthetic 
polymers and solid state peptides.22, 23  
R'NH2 +
O
N
R H
OO
R'
H
N
N
H
OH
R
O
O
R'
H
N
NH2
R
O
+   CO2
R'
H
N
NH2
R
O
n
+nCO2
n NCA
 
Scheme 3. Mechanism for NCA ROP initiated by nucleophilic amine. 
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1.1.4. Controlled/Living radical polymerization (CLRP) 
Conventional free radical polymerization has an enormous industrial importance. 
Approximately 50% of all commercially available polymers are produced by radical 
polymerization, because it can be applied to a wide range of monomers (mainly vinyl, acrylic 
and methacrylic family monomers) under mild reaction conditions with wide temperature 
range (going from -80 °C to 250 °C).24 However, the major drawback is that conventional free 
radical polymerization proceeds with very limited control, due to occurrence of biomolecules 
coupling and disproportionation termination and chain transfer reactions of propagating 
chains with polymer chains, initiators, monomers and solvent molecules during the 
polymerization, mainly caused by the high reactivity of radicals.25 As a result, it is impossible 
to synthesize polymers with regular chemical structures and narrow PDIs. Along with 
conventional free radical polymerization, CLRP developed rapidly. CLRP maintains not only 
the advantages of conventional free radical polymerization, like a wide selection of 
monomers and mild reaction conditions, but also has its own advantages, such narrow PDIs 
of the synthesized polymers, preservation of functional groups, and possibility of 
synthesizing block copolymers with complicated structures.26 Figure 1 illustrates the 
influence of CLRP and conventional radical polymerization for one monomer on the final 
molecular weights (Mn) and PDIs. 
 
Figure 1. A general comparison of polymers synthesized by conventional radical 
polymerization and Reversible Addition-Fragmentation Chain Transfer Polymerization 
process. (http://www.sigmaaldrich.com/materials-science/polymer-science/raft-
polymerization.html#sthash.PP5REwUp.dpuf) 
 
The majority of CLRP systems developed to date proceed via one of two basic mechanisms: (i) 
The persistent radical effect and (ii) degenerative transfer.25 Among the CLRP, Nitroxide-
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Mediated Radical Polymerization (NMP), Atom Transfer Radical Polymerization (ATRP), and 
Reversible Addition-Fragmentation Chain Transfer Polymerization (RAFT) are most applied to 
synthesize polymers with a high degree of control.27 The mechanism of NMP, ATRP and RAFT 
are depicted in Scheme 4. 
P-T
kact
kdeact
P
.
+ T
.
dead polymerA:
P-X 
 +  Mtn
 
/ ligand
kact
kdeact
Kp
monomer
P
.
dead polymer
Kp
monomer
+ Mtn+1X / ligand
B:
X = Cl, Br, I
Mt = Cu, Ru, Fe, Ni, Pd, Rh
Pm
.
+
dead polymer
Kp
monomer
S S
R
Z
kad, 1
kB, 1
S S
R
Z
Pm
. kB, 2
kad, 2
S S
Z
Pm
R
.
dead polymer
Kp
monomer
+
Pre-equilibrium
Pm
.
+
dead polymer
Kp
monomer
S S
Pn
Z
kad
kB
S S
Pn
Z
Pm
. kB
kad
S S
Z
Pm
Pn
.
dead polymer
Kp
monomer
+
kt
kt
C:
 
Scheme 4. Mechanism of the (A) NMP, (B) ATRP and (C) RAFT. kdeact: deactivation rate 
coefficient (M-1 s-1), kact: activation rate coefficient (s-1), kex: degenerative chain transfer rate 
coefficient (M-1 s-1), kp: propagation rate coefficient (M-1 s-1), kt: termination rate coefficient 
(M-1 s-1). 25 
 
The advanced development of CLRP has led to the synthesis of polymers with various 
chemical structures (linear, grafted, multi-armed, combed, networked and hyper branched 
structures).28-30 CLRP has also contributed to the development of other researches based on 
polymers, for example the synthesis, self-assembly of ABPs, and applications thereof.31, 32  
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1.1.5. Other polymerization techniques  
Beyond living ionic polymerization, ROP, and CLRP techniques, there are also several other 
types of polymerizations, such as polycondensation.33 Polycondensation is a typical step-
growth polymerization with loss of small molecules during the polymerization process, such 
as water and carbon dioxide (scheme 5).34 In order to obtain high Mn polymers, controlling 
the same amount of reactants and elimination of newly formed small molecules are crucial. 
Recently, click chemistry has been applied in polycondensation. Suhrit Ghosh et al. used 
divinyl monomer (M1) and dithiol monomer (M2) to synthesize polymers basing thiol-ene 
click chemistry (Scheme 6).35 Also, Krishna Dan et al. reported the synthesis of acid-labile 
ABPs with “thiol-ene click polycondensation” by introducing another hydrophiphilic polymer 
with a mono acrylate as ending group at the end point of polycondensation (Scheme 7).36 In 
contrast to the mechanism shown in Scheme 5, no small molecules were formed during the 
“thiol-ene click polycondensation”. Therefore, elimination of the newly formed small 
molecules during the “thiol-ene click polycondensation” is no longer required anymore. 
HO-R-OH 
   +    XOC-R'-COX O-R-O-OC-R'-CO + 
  
2HX
R, R' = aliphatic, cycloaliphatic, heterocyclic or aromatic
X = H, Cl, Br
Kp
Kd
 
Scheme 5. Mechanism of polycondensation. 
 
O
O
O
O
+ HS SH
HS
OH
HO
S O O S S
O O
O O S
OH
O O
6 6
1. Me2PPh, DMAc, 1h
n
2.
 
Scheme 6. Synthetic procedure of bi-functional polymers through “thiol-ene click 
polycondensation”.35 
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Scheme 7. One-pot synthesis of ABPs with “thiol-ene click polycondensation”.37 
 
With the development of various polymerization techniques, polymer chemists can specially 
design and synthesize different polymers with new chemical selective structures and 
interesting properties. For example, the introduction of polymer blocks or groups with pH-,37 
redox-,38 light-,39 thermal-,40 enzyme-responsiveness41 have allowed the synthesis of smart 
ABPs.  
1.2. ABP self-assembly 
An ABP is one type of polymer, which is constituted by hydrophobic and hydrophilic blocks 
connected through covalent bonds or by supermolecular interactions.42, 43 ABPs can be linear, 
star, cyclic, combed or hyperbranched depending on the used synthetic strategy and 
monomers (Figure 2).44, 45  
 
Figure 2. Possible ABPs architectures: A: linear AB diblock, B: star ABC triblock, C: cyclic AB 
block, D: comb AB block, E: miktoarm star block, F: multiblock, G: supermolecular AB diblock.  
 
Because ABPs have similar structure with small molecule surfactants and lipids, the 
incompatibility between the molecular segments leads to local segregation or microphase 
separation in bulk,46, 47 which means the microphases of each blocks are not lacated at 
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random but they may form a regular arrangement giving rise to a periodic structure.48 The 
microphase separation of ABPs depends on three parameters: (i) the volume fraction of the 
A and B blocks (fA and fB, with fA + fB = 1), (ii) the total degree of polymerization (DP) (N = NA 
+ NB), and (iii) the Flory-Huggins interaction parameter (χAB). The microphase separation 
structure phase diagram predicted according to the self-consistent mean-field (SCMF) theory 
and experimental phase portrait of polyisoprene-block-polystyrene of amphiphilic diblock 
copolymer are shown in Figure 3.49 However, for the amphiphilic multiblock copolymers, 
understanding the microphase separation is even more complicated.  
 
Figure 3. Equilibrium morphologies of amphiphilic diblock copolymers in bulk: S and S’ = 
body-centered-cubic spheres, C and C’ = hexagonally packed cylinders, G and G’ = 
bicontinuous gyroids, and L = lamella. (b) Theoretical phase diagram of amphiphilic diblock 
copolymers predicted by the self-consistent mean-field theory, depending on volume 
fraction (f) of the blocks and the segregation parameter, χN, where χ is the Flory-Huggins 
segment-segment interaction energy and N is the degree of polymerization; CPS and CPS’ = 
closely packed spheres. (c) Experimental phase portrait of polyisoprene-block-polystyrene 
copolymers, in which fA represents the volume fraction of polyisoprene, PL = perforated 
lamellae.49  
 
As just described ABPs can form various microphase separation structures in bulk, and in 
aqueous solution, they are also able to self-assemble into various nanostructures.50, 51 The 
self-assembled nanostructures are with the hydrophilic blocks facing the aqueous 
environment, and the hydrophobic blocks orienting in the opposite direction to minimize the 
interaction with the aqueous environment. The final morphology of self-assembled 
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nanostructures are determined by several factors: i) the nature of constituted blocks (Mns,52 
PDI53, 54 and chemical composition);55 ii) external conditions, including temperature,56 pH,57 
salt concentration,58 content of solution59 and ABP concentration;60 iii) preparation method; 
including film rehydration, cosolvent and electroformation.61 Micelles, worm-like micelles, 
and vesicles are the three most common types of reported nanostructures (Figure 4).47 In 
addition, some other special nanostructures were also reported, for example biocontinuous 
rods, lamellar structures, multilamellar vesicles and large compound micelles.62, 63 The 
packing parameter, p = v/a0lc (Figure 4), determines the morphology of self-assembled ABPs, 
where v is the volume of the hydrophobic segment, a0 is the contact area of the head group, 
and lc is the length of the hydrophobic segment.64 When p < 1/3, spheres are formed; when 
1/3 < p <1/2, cylinders; when 1/2 < p < 1, flexible lamellas or vesicles; finally, when p = 1, 
planar lamellas are obtained.47, 50 The transition of morphologies can be attributed to two 
competing factors: interfacial energy between the two blocks and stretching. As microphase 
separation occurs, the two blocks separate from each other in such a way as to minimize 
interfacial area to lower the total interfacial energy. Phase separation induces chain 
stretching away from preferred coiled polymer chain conformation; the degree of stretching 
depends on the volume fraction of one block relative to that of the diblock. Figure 4 shows 
the well-known cone-column mechanism for morphological transitions.65  
 
Figure 4. Self-assembled morphologies formed by ABPs in a block-selective solvent. The type 
of morphologies formed is due to the inherent curvature of the molecule which can be 
estimated through a calculation of its dimensionless packing parameter, p.65 
 
Compared to lipids, ABPs have a higher Mn. Therefore, their self-assembled nanostructures, 
for example vesicles, exhibit stronger hydrophobic interactions and a higher membrane 
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thickness, affording them a higher mechanical resistance and a lower permeability than their 
lipid counterparts.66, 67 In addition, as described above, by choosing the appropriate 
polymerization techniques and monomers, various functionalities can be endowed with the 
self-assembled nanostructures of ABPs.38,41,68,69 That explains why the ABPs in general, and 
their self-assembled nanostructures attracted so much interest in the past years from the 
polymer community to pharmaceutical and medical application. 
1.3. Responsive amphiphilic block copolymers (RABP) 
RABP is a kind of ABPs with special functional motifs, which endow the ABPs and 
corresponding self-assemblies with unique functionality or responsibility.70 The commonly 
appeared functionalities are pH-responsive groups, thermo-responsive groups, enzyme-
responsive groups, light-responsive groups, redox-responsive groups and so on.71, 72 Through 
pinpoint chemistry design, such smart groups or functionalities can be incorporated into side 
chains and tips of ABPs or as linkers between different blocks.73 Noticeably, some of the 
RABP can have more than one functionality, for example, Hui Zou et al recently synthesized 
smart ABP poly(ε-carprolacton)-ss-poly(2-(N,N-dimethylamino)) (PCL-ss-PDEAEMA) with 
thermo- and redox- responsibility through ROP and ATRP techniques.74  
1.3.1. RABPs with redox-responsibility 
Most of the redox-responsive group which used in ABPs synthesis is disulfide group (-SS-). 
The disulfide bridge can be break by reduction agent with thiol groups through thiol-disulfide 
exchange reaction, for example glutathione (GSH). The reason why redox-responsive ABPs 
are popular is that: i) disulfide group can be conveniently incorporated into ABPs structure 
by using commercial disulfide-based monomers, ATRP and RAFT agents, functional linkers, 
and so on;75 ii) the existence of a large difference in reducing potential between extracellular 
fluids and the intracellular environment (2-20 µM and 0.5-10 mM of glutathione 
respectively);76 iii) the reaction between reducing agent and disulfide can happen in broad 
condition, including pH values and reaction solution (organic solvents and aqueous 
solution).77             
1.4. Applications of ABPs and their self-assembled nanostructures 
During the self-assembly process of ABP in aqueous solution, hydrophobic molecules 
(hydrophobic drugs,78 porphyrin-based near infrad (NIR) supramolecular fluorophores79 and 
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magnetic nanoparticles80) and hydrophilic molecules (proteins81,82), can be encapsulated into 
the hydrophobic and hydrophilic domain, respectively.83 The procedure of encapsulating 
guest molecules is presented in Figure 5. By confining selected active molecules in enclosed 
structures, these nanosystems are promising candidates for targeted and triggered drug 
delivery system.84,85,86 Polymersome as one of the most important self-assembled 
nanostructures of ABP can be possible to combine with proteins and enzymes to mimic 
organelles for therapeutic applications.87 Interestingly, a membrane protein with two 
hydrophilic ends and a hydrophobic center, can be inserted into the hydrophobic domain of 
a polymersome to allow passive or active passage of substrates across the polymersome 
membrane, making it as a nanoreactor.88 In nanoreactor, specific reactions can take place in 
a limited and confined apace.89 The most interesting, after a nanoreactor is uptaken by cells, 
they can act as an artificial organelle inside of cells.87 In addition, the self-assemblies surface 
can be modified by various targeting molecules (folic acid, antibodies and proteins) to 
accomplish selective targeting (Figure 6).90  
 
Figure 5. Guest molecules entrapment into the self-assemblies formed by ABPs. 
 
 
Figure 6. Encapsulation of enzymes into the self-assemblies, insertion of membrane proteins 
into hydrophobic membrane and surface modification with specific targeting molecules.  
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Because of the amphiphilicity of ABPs, and the ability of encapsulating hydrophobic and 
hydrophilic molecules in the ABPs self-assemblies, ABPs and their self-assemblies have been 
used in following application and research areas: macro-emulsifiers, diagnostics, cancer 
therapeutics (including anti-cancer drugs and genes delivery), infectious diseases treatments, 
and nanoreactors.73, 88, 91-98 
1.4.1. Emulsifier 
Because ABPs contain hydrophobic and hydrophilic blocks, they can be used as macro-
emulsifiers (polymeric surfactants) to stabilize the hydrophobic droplets in aqueous solution 
(O/W), or water droplets in an organic solvent (W/O). Compared with the smaller molecular 
weight emulsifiers, ABPs have several advantages: i) higher stability than small molecule 
emulsifiers due to the higher Mn and longer molecular chains; ii) chemical and physical 
properties can be designed by varying the constituting monomers and advanced 
polymerization techniques. Mickael Chausson et al reported using of poly(caprolactone)-
block-poly(ethylene oxide) (PCL-b-PEO) as the macro-emulsifier to stabilize nanoemulsions 
formed by hydrophobic PCL and Vitamin E acetate. Emulsification by nanoprecipitation 
process was successful when the PCL-b-PEO was added into the organic phase, especially for 
higher Mn of the PEO block (DP above 45). The stabilizing effect of PCL-b-PEO was similar to 
that reported for ethylene oxide/propylene oxide triblock copolmyers (Pluronic).96 
Poly(butadiene)-block-poly(ethylene glycol) (PBD-b-PEG) was a more effective macro-
emulsifier to stabilize computed tomography (CT) blood pool contrast agents (Figure 7) 
when compared with the lipid-stabilized emulsions. Moreover, the blood circulation half-life 
time of a PBD-b-PEG stabilized emulsion is approximately 3 h and shows no toxicity in vivo.99 
The longer blood circulation half-life time can be attributed to higher Mn of PBS-b-PEO. 
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Figure 7. Schematic representation of a stabilized emulsion as a CT contrast agent showing 
lipid emulsifier and macro-emulsifier PBD-b-PEG. (A) The unweighted hydrophobic radius 
and distribution result from DLS and (B) Cryo-TEM of hydrophobic oil droplet.99  
 
1.4.2. Medical application 
ABP self-assembly structures have a wide range of biomedical applications ranging from drug 
delivery systems to artificial organelles. One of the most important medical applications of 
ABPs is anticancer therapy because of enhanced permeability and retention (EPR1) effect, 
defined by an enhanced uptake of loaded self-assemblies of ABPs with diameter lower than 
200 nm by tumors.97, 100 Moreover, low Mn compounds can enter into both normal and 
tumor tissues through the endothelia cell layer of blood capillaries by free diffusion-
dependent equilibrium (Figure 8), while high Mn compounds (polymers, self-assembled 
nanostructures) cannot pass the endothelial cell barrier of normal tissue. Instead, they are 
uptaken into the tumors' leaky vasculature and remain there until taken up by the tumor 
cells. In normal tissue, the clearance of macromolecules and small size particles occur rapidly 
and steadily via the lymphatic system, whereas in tumor tissue the drainage system is 
defective. Macromolecules are retained in the tumor and accumulate high doses 
independent of the specific type of tumor.101 This unique phenomenon in solid tumors, EPR1 
effect, is considered to be a landmark principle in tumor-targeting chemotherapy and 
become a promising paradigm for anticancer drug development. By encapsulating of anti-
cancer drugs in the self-assemblies of ABPs, they will be transported preferential only to 
tumors decreasing in toxicity of anti-cancer drug to normal tissues.102 That is why utilizing 
ABPs self-assembled nanostructures loading with anti-cancer drugs is one of the most 
promising cancer therapy alternatives. 
 
Figure 8. Schematic representation of EPR1 effect to the small molecules and 
nanoparticles.93 
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Recently, stimuli-responsive self-assemblies of ABPs have been used for anti-cancer drug 
delivery.70, 73, 97 Their fast development of these smart self-assemblies of ABPs is due to the 
presence of special stimuli-responsive functional groups as described above. 41, 93, 94,103,104,71, 
105 Assaf J. Harnoy et al. synthesized an amphiphilic PEG-dendron, which self-assembled into 
micelles in aqueous solution. The end functional groups of the dendrons contain phenyl 
acetamide groups that are hydrophobic and can be cleaved by enzyme penicillin G amidase 
(PGA). When the micelles were exposed to PGA, the structures of micelles were destabilized 
and the encapsulated guest molecules were released (Figure 9).106 
 
Figure 9. (A) Schematic representation of the encapsulation of hydrophobic compounds in 
the hydrophobic core of enzyme-responsive micelles. Upon enzymatic cleavage of the 
hydrophobic end groups, the micelles disassembled and the guest molecules were released. 
(B) Fluorescence spectra of Nile red (1.25 µM) in the presence of PEG-dendron (160 µM) as a 
function of time after the addition of PGA (0.14 µM). Fluorescence intensity decreased as 
Nile red was released into solution.106  
 
ABPs are not only applied in anticancer therapy, but can be also used for treatment of 
various infectious diseases and in diagnostics. We reported that polymersomes formed from 
a mixture of PDMS-heparin block copolymers with poly(2-methyl-2-oxazoline)-block-
poly(dimethylsiloxane)-block-poly(2-methyl2-oxazoline) (PMOXA-b-PDMS-b-PMOXA) can 
efficiently inhibit malaria parasites to attach to host cells and therefore to interrupt the life-
cycle of the pathogen by invasion inhibition. The results showed that these nanomimics 
efficiently blocked the reinvasion of malaria parasites after their egress from host cells, and 
exhibited efficiency of more than two orders of magnitude higher than the soluble form of 
the heparin-receptor (Figure 10). 
1. Introduction 
 
15 
 
 
Figure 10. Schematic representation of the nanomimic concept. Left: life cycle of P. 
falciparum in the human host: an Anopheles mosquito injects sporozoites, which pass 
through Kupfer cells and invade hepatocytes, in which merozoites develop and are released 
into the blood stream to invade red blood cells (RBCs) after specific attachment to heparan 
sulphate.107 In infected RBCs (iRBCs) merozoites develop through schizogeny releasing 16 - 
32 daughter merozoites after 48 h, which subsequently invade new RBCs (asexual blood-
stage). Right: schematic merozoite invasion into RBCs. An initial attachment through binding 
of the processed ligand MSP142 to heparan sulphate on RBCs.107 Competing nanomimics (red 
circles) block fresh merozoites before they enter new RBCs (white arrow) (modified with 
permission from108). 
 
Yiguang Wang et al. reported that ultra pH-responsive nano probes formed by self-assembly 
of ABP cRGDfK-poly(ethylene glycol)-block-poly(2-(diisopropyl amino)ethylmethacrylate) 
copolymer with conjugated near-infrared dye, Cy5.5 (cRGD-PEG-b-(PR-r-NIR) can be used as 
a diagnostics nanoreporter (Figure 11). At pH ˃ 7.0, these nanostructures were stabilized by 
the hydrophobic interaction, and the homo-fluorescence resonance energy transfer 
(homoFRET) induced fluorescence of the dye was quenched (representing the “OFF” state). 
However, when the pH decreased < 7.0, the tertiary amine was protonated, and the 
hydrophobic domain of the nanostructures changed to hydrophilic resulting to increase the 
distance between fluorescent dye molecules. In this manner, the fluorescence of the dyes 
was not quenched (“ON” state). Because the pH is lower in tumor cells, these structures 
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showed no fluorescence while circulating in blood steam, but showed a high fluorescent 
signal in tumors after the nanoprobes were uptaken by the acidic cancer tissue.109 It should 
be noted that ABPs used in medical application should be biocompatible and biodegradable. 
Table 1 listed some examples of ABPs which have been used for medical applications. 
 
Figure 11. A. Chemical structure of ABPs used as the nanoprobes, UPSi (chemical structure is 
shown in inset of Figure 11A) can be activated inside acidic endocytic organelles (pHi = 5.0-
6.0). B. nanoprobes changing state from “OFF” to “ON”. C. Normalized fluorescence intensity 
as a function of pH for UPSi nanoprobes, the nanoprobes can be activated as a result of 
micelle dissociation. D. UPSi nanoprobes remain stable in fresh mouse serum over 24 h at 
37 °C. E. Representative images of ex vivo tumours, muscles and blood at 6 h post-injection 
of nanoprobes.109  
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Table 1. Examples of ABPs used for medical applications (2013 and 2014). 
ABPs 
Active 
molecules 
functionality morphology of self-assemblies Ref. 
PEG-b-PLGA DTX  Micelles 110 
PEG-star-PCL DOX.HCl Redox-responsive Micelles 111 
PEG-b-PCL-b-PAA DOX pH-responsive Vesicle 112 
PCB-b-PDPA DOX pH-responsive Nanoparticles 113 
DL-ssAB DOX Redox-responsive Micelles 114 
mPEG-SS-VES Ator Redox-responsive Micelles 115 
PEG-XPLG*LAGr9 
X-PCL 
siRNA  Micelles 116 
PLLA-b-peptide-
PLLA 
fluorouracil 
Enzymatic-
responsive 
Nanoparticles 117 
ELP-b-PEG 1,8-ANS pH-responsive Nanoparticles 118 
PEG-SS-PTMBPEC DOX 
pH-responsive and 
Redox-responsive 
Micelles 119 
PCL-b-P(OEGMA- 
co-MAEBA 
CPT 
pH-responsive and 
Redox-responsive 
Micelles 120 
PEG-b-PAD Myoglobin CO2- responsive Vesicle 121 
PEO-b-P(DEA-stat 
-TMA) 
DOX 
pH and ultrasound 
responsive 
Vesicle 92 
Mal-PEG-b-P(Glu) DACHPt  Micelles 122 
PEG-PUSeSe-PEG DOX light responsive Nanoparticles 91 
PEG-b-PLA SiQDs  Nanoparticles 123 
 
1.4.3. Nanoreactors 
Nanoreactors are new and exciting structures represented by vessels carrying out defined, 
chemical reactions in a confined nano-scale space.89, 95 In order to be defined as a 
nanoreactors, the vessels must fulfill the following requirements: (i) efficient encapsulation 
of desired catalysts within their cavity; (ii) a physical stable membrane to protect the 
encapsulated catalysts; iii) polymer membrane with selective permeability allowing the 
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passage of certain reactants and products.89 Due the higher Mn of ABPs, the self-assembled 
polymersomes with high mechanism stability membrane and several hundred nanometers 
diameters address the first two mentioned requirements. However, due to lack of 
permeability of hydrophobic polymer membrane for small molecules and ions,98, 124-127 
finding solutions to allow the passage of reactants and products is critical to create a 
nanoreactor. In order to induce permeability through polymer membranes, various methods 
have been used. For example, insertion of membrane proteins we describe above.98, 128, 129, 
95, 126. Recently, Karolina Langowska et al. inserted outer membrane protein F (OmpF) into 
the membrane of PMOXA-b-PDMS-b-PMOXA self-assembled polymersome. The 
encapsulated penicillin acylase w Penicillin acylase inside of the polymersome can catalyze 7-
aminodesacetoxycephalosporanic acid (7-ADCA) and phenylglycine methyl ester (PGME) to 
form antibiotic cephalexin. This nanoreactor system could synthesize antibiotics in the cavity 
of polymersomes, and the synthesized antibiotics can be transferred from inside through 
OmpF to outside inhibiting bacterial growth. The detailed design of antibiotic self-generating 
implants is presented in Figure 12.89 
 
Figure 12. (A) Schematic representation of antibiotic nanoreactor producing cephalexin. (B) 
Picture of the MHB agar plate inoculated with bacteria. Inhibition areas: 1: control (not 
permeable polymersomes); 2: substrate solution; 3: nanoreactors prepared at RT; 4: 
nanoreactors prepared at 8 °C; after incubation for 24 h at 37 °C. No zones of inhibition were 
observed around control or substrate disks.89 
 
Nanoreactors with selective permeability can be obtained by using a mixture of polyethylene 
glycol-block-polystyrene (PEG-b-PS) with poly(ethylene glycol)-block-poly(styrene boronic 
acid) (PEG-b-PSBA) as two types of different ABPs. By increasing the pH value, the solubility 
of the PSBA block in water increases when boronic acid is ionized to boronate, which makes 
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the copolymers of PEG-b-PSBA change from amphiphilic to hydrophilic allowing them to 
diffuse from the polymersome. Because the PS is a crystal polymer, the original space 
occupied by PSBA cannot be filled by the PS, and pores are formed in the membrane (Figure 
13).130 Interestingly, the chemical method can also be applied to create to pores on the 
membrane of polymersomes.125 For example, UV-irradiation of 2-hydroxy-4-2-
(hydroxyethoxy)-2-methylpropiophenone (PP-OH) added into the polymersome solution of 
PMOXA-b-PDMS-b-PMOXA, and poly(ethylene oxide)-block-poly(butadiene) (PEO-b-PBD), 
induced the increase of polymer membrane permeability to create nanoreactors (Figure 14).  
 
Figure 13. (A) Molecular structures of block copolymers, PEG-b-PSBA, and their equilibrium 
with sugar molecules in a basic aqueous phase. Complete ionization of boronic acid groups 
was assumed for simplicity. (B) Schematic representation of the formation of nanoreactors 
with a permeable membrane utilizing the sugar responsiveness of the block copolymers.130 
 
Figure 14. Schematic representation of nanoreactor produced by photoreaction of 
hydroxyalky phenone.125 
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1.5. Motivation and concept.  
The influence of different parameters presented in the part of 1.2. on the self-assembled 
morphologies of ABPs have been reported by several papers using different ABPs. However, 
in depth and systematic analyses of various factors simultaneously affecting the self-
assembly process is still needed. Due to the promising applications of ABPs in medical field, 
the development of new smart nanocarriers for drug and/or gene delivery is also interesting. 
In this respect, we aim to synthesize three different ABPs, poly(dimethylsiloxane)-block-
poly(2-methyl-2-oxazoline) (PDMS-b-PMOXA), poly(2-methyl-2-oxazoline)-graft(ss)-
poly(caprolactone) (PMOXA-graft(ss)-PCL) and poly(2-ethyl-2-oxazoline)-block-
poly(caprolactone)-block(ss)-poly(L-lysine) (PEtOXA-b-PCL-ss-PLL), and investigate the 
different parameters that influence the self-assembly behaviors for the ABPs system of 
PDMS-b-PMOXA, and evaluate potential application for different medical applications of 
PMOXA-graft(ss)-PCL and PEtOXA-b-PCL-ss-PLL ABPs systems. The synthesized ABPs should 
fulfill the following requirements: 
(i) They self-assemble nanostructures in aqueous solutions. 
(ii) Reproducible synthesis employing the conventional polymerization techniques. 
(iii) Biodegradability and biocompatibility. 
(iv) Ability to entrap various selected drugs or plasmids inside the formed self-assembled 
structures. 
In order to accomplish this aim, various diblock copolymers PDMS-b-PMOXA were 
synthesized through the anionic and cationic ROP techniques. That are designed specifically 
to facilitate the study of the effect of the Mn of both hydrophobic and hydrophilic blocks on 
the self-assembly behavior. The initial concentrations of copolymers, preparation methods 
for the supramolecular assemblies, and the contents of the aqueous solution are taken into 
account. Also, a new reduction responsive ABP with grafted polymer structure, PMOXA-
graft(ss)-PCL, was synthesized through ROPs and a thiol-disulfide exchange reaction. The cell 
toxicity of ABPs and the anti-cancer profile of DOX loaded nanoparticles formed by ABPs 
were tested. In addition, in order to achieve the gene delivery, a third ABP with linear 
triblock structure, PEtOXA-b-PCL-ss-PLL was synthesized. Due to the negative charge of the 
DNA backbone, it can be complexed through charge interaction by the positive charge of the 
PLL block during the self-assembly of PEtOXA-b-PCL-ss-PLL. The overall performance of 
PEtOXA-b-PCL-ss-PLLs as gene delivery nanocarriers should be investigated in more depth.  
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 2. Effect of molecular parameters on the architectures and 
membrane properties of 3D assemblies of amphiphilic 
copolymers 
Dalin Wu, Mariana Spulber, Fabian Itel, Mohamed Chami, Thomas Pfohl, Cornelia G. Palivan*, 
and Wolfgang Meier* 
The result have been published on the journal of Macromolecules 
Macromolecules, 2014, 47 (15), pp 5060–5069  
2.1. Introduction 
ABPs represent one of the most promising self-assembling materials, because they form in 
dilute aqueous solutions a variety of supramolecular assemblies, such as polymersomes, free 
standing films, tubes, micelles, or hard spheres.65 The architectures and properties of these 
synthetic supramolecular self-assemblies can be optimized by selecting a specific chemical 
structures of ABPs (chemical nature, block lengths, modulation of their hydrophilic-to-
hydrophobic ratios), or by chemical modification functionalization.50,131 
Interesting architectures in terms of possible novel applications of ABPs are polymeric 
vesicles or polymersomes, which are nanometer size compartments generated by self-
assembly in dilute aqueous solution. They offer three different topological regions 
(membrane, external surface and inner cavity) that serve as appropriate locations for 
encapsulating active molecules, such as proteins, enzymes, mimics, genes, contrast agents, 
etc.95, 132, 133 The hydrophobic membrane facilitates insertion of hydrophobic molecules, the 
external surface can be functionalized with specific molecules to support targeting 
approaches or immobilization on solid supports, whilst the inner cavity has the role of a 
confined space where hydrophilic active molecules can be encapsulated. A major advantage 
of polymersomes, which supports their application as drug delivery systems, is their dual 
role: they prevent leakage of encapsulated molecules from inner cavity, and protect them 
against exterior degradation agents.134 A further step in the development of applications for 
polymersomes is to design nanoreactors by using their inner cavity as a confined space, in 
which reactions occur when catalytically active compounds are encapsulated.98 To support 
nanoreactor functionality, the polymersome membrane has to allow an exchange of 
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substrates/products with the environment whilst preserving the spherical architecture of 
vesicles. Permeability of the membrane is achieved either by chemical modification,125, 130 or 
by insertion of channel proteins.98 To accomplish the insertion of membrane proteins in the 
hydrophobic shell of polymersomes, the ABPs should address at least three requirements: i) 
the hydrophobic blocks should be with quite flexibility without crystal structures (low glass 
transition temperature (Tg)); (ii) the thickness of the polymersome membrane should be in 
the same range of the membrane proteins. A large variety of nanoreactors have been 
produced by encapsulating proteins,124 enzymes,135 mimics81 or combinations thereof that 
offer the possibility to mimic natural organelles inside of cells.95 
In the present thesis, the synthesis of a library of ABPs poly(dimethylsiloxane)-block-poly(2-
methyl-2-oxazoline) (PDMS-b-PMOXA), which are designed specifically to facilitate the study 
of the effect of the Mn of both hydrophobic and hydrophilic blocks on the self-assembly 
behaviors are described. The initial concentrations of copolymers, preparation methods for 
the supramolecular assemblies, and the contents of the aqueous solution are taken into 
account, and a combination of light scattering, TEM and cryo-TEM have been used to 
characterize the supramolecular assemblies. Due to the low Tg value (-123 °C), very low 
surface energy and physiological inertness of PDMS,136 the self-assembled polymersome 
formed by PDMS-b-PMOXA will be the candidates for the insertion of membrane proteins to 
serve as nanoreactors and/or artificial organelles. In order to obtain greater insight into the 
organization of the hydrophilic and hydrophobic domains of the polymersomes, we have 
investigated the interaction of spin-probes with the polymer membranes of the 
polymersomes by electron paramagnetic resonance (EPR) to provide information on local 
flexibility and polarity of the polymer membranes. Such information is essential when 
planning the insertion of membrane proteins into polymersome membranes for nanoreactor 
development.  
2.2. Results and discussion 
2.2.1. Synthesis and characterization of PDMS-OH, PDMS-OTf and PDMS-b-PMOXA 
ABPs 
PDMS-OH was obtained by hexamethylcyclotrisiloxane (D3) through anionic ROP in presence 
of n-butyllithium (Scheme 8). The freshly dried and distilled D3 was initially mixed with n-
butyllithium in anhydrous cyclohexane to form the anionic initiator. Chain propagation 
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started after addition of freshly distilled THF which favors the presence of loose ion pairs and 
can further initiate the ROP of D3. The anionic ROP of D3 suffers from a backbiting reaction 
when the monomer concentration decreases more than 80% at room temperature. Because 
the backbiting reaction competes with the propagation,137 the polymerization should be 
quenched to avoid the formation of cyclic PDMS molecules before the monomer 
concentration decreases by 80%. Cyclic PDMS molecules cannot further participate in the 
functionalization, so any free PDMS can affect the further synthesis and PDIs of the PDMS-b-
PMOXA. Quenching was performed by reacting with chlorodimethylsilane, introducing the 
silane (SiH) group as the end functional group of linear PDMS (PDMS-SiH) (Figure 15-A). Next, 
hydrosilyzation between PDMS-SiH and 2-allyloxyethanol was performed in order to obtain 
PDMS-OH. When hydrosilyzation was carried out at 60 °C with 50 mM Pt(dvs) as catalyst, 
even after over 24 h, the peak of proton on end silane group (SiH) was still present in the 1H 
NMR spectrum, indicating the incomplete hydrosilyzation reaction. After increasing the 
temperature to 110 °C, the complete modification by 2-allyloxyethanol was accomplished, 
where the peak of Si-H proton at 4.85 ppm disappeared completely. The appearance of new 
peaks at 3.86 ppm, 3.72 ppm and 3.60 ppm characteristic for the protons of 2-
allyloxyethanol structure (Figure 15-B) proved that the PDMS-OH has been successfully 
synthesized. Three different PDMS-OH polymers with increasing DP: 16, 39 and 65 units 
were synthesized (Table 2).  
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Scheme 8. Synthesis route of PDMS-OH, PDMS-OTf and PDMS-b-PMOXA ABPs. 
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Figure 15. 1H NMR spectrums of silane terminated PDMS-SiH, PDMS-OH and PDMS-OTf. 
 
 
Figure 16. GPC curves of PDMS65-OH, PDMS39-OH and PDMS16-OH with THF as the running 
phase. 
 
The PDIs of these PDMS-OH polymers were 1.11, 1.08 and 1.12, respectively (Figure 16). 
Because water is a known quenching agent for the ROP of 2-methyl-2-oxazoline, the 
obtained PDMS-OH was dried by refluxing with toluene in a Soxleth apparatus containing 4Å 
molecular sieves overnight before further use. The dried PDMS-OH was reacted with 
trifluoromethanesulfonic anhydride to synthesize the PDMS-OTf macroinitiator. The 
chemical structure was characterized by 1H NMR (Figure 15-C). After forming the triflate 
ester, the chemical peaks characteristic for protons on carbon b and c of PDMS-OH were 
completely shifted from 3.86 ppm and 3.71 ppm to 4.77 ppm and 3.94 ppm, respectively. 
This indicated that all the hydroxyl group of PDMS-OH were activated. The ROP of 2-methyl-
2-oxazoline in acetonitrile initiated by triflate ester is a living cationic ROP.138 However, the 
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acetonitrile was not a good solvent for the macroinitiator PDMS-OTf, so a mixture of 
chloroform and acetonitrile was used instead (Vchloroform : Vacetonitrile = 7 : 3). The 
polymerization reaction kinetics was examined by 1H NMR, and the result is shown in Figure 
17. By increasing the polymerization time, the integrals of the protons on 2-methyl-2-
oxazoline (δ = 4.20 ppm and δ = 3.76 ppm) decreased gradually, while those characteristic 
for poly(2-methyl-2-oxazoline) (PMOXA) (δ = 3.42 ppm and δ = 2.07 ppm) increased (Figure 
17). The ROP of 2-methyl-2-oxazoline obeyed a first order kinetics as shown in Figure 18, 
which indicated that the lengths of the PMOXA blocks can be easily controlled by changing 
polymerization time.  
 
 
Figure 17. 1H NMR spectrum of polymerization propagation of 2-methyl-2-oxazoline initiated 
by PDMS-OTf in different polymerization time.  
 
Figure 18. The kinetic of polymerization of 2-methyl-2-oxazoline initiated by PDMS-OTf in 
the chloroform and acetonitrile (V/V= 7:3) mixture solvents at 40 °C. (M0: initial 
concentration of 2-methy-2-oxazoline; M: concentration of 2-methy-2-oxazoline in each 
reaction time).  
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We selected three hydrophobic PDMS-OH polymers with increasing DP: 16, 39 and 65. 
Variable hydrophilic PMOXA block with variable DP (ranging from 3 to 38 units) were 
coupled by living cationic ROP of 2-methyl-2-oxazoline. The library of PDMSx-b-PMOXAy ABPs 
allowed the investigation of how to tune the formation of supramolecular assemblies with 
selected morphologies by varying the hydrophilic to hydrophobic block length ratio 
(fPMOXA = 𝑀𝑛 𝑜𝑓 𝑃𝑀𝑂𝑋𝐴𝑀𝑛 𝑜𝑓 𝑃𝐷𝑀𝑆 ) (Table 2).  
Table 2. Molecular characteristics of PDMS-OH and PDMS-b-PMOXA ABPs. 
Samplea,b Mn a (KDa) fPMOXAc f*d 
A65 5.00   
A65B10 5.88 16% 14% 
A65B12 6.05 20% 16% 
A65B14 6.18 24% 19% 
A65B16 6.35 27% 21% 
A65B19 6.59 31% 24% 
A65B26 7.14 44% 31% 
A65B32 7.68 53% 35% 
A65B38 8.19 64% 39% 
A39 3.10   
A39B6 3.61 16% 14% 
A39B7 3.69 19% 16% 
A39B8 3.77 22% 18% 
A39B9 3.85 24% 19% 
A39B10 3.94 27% 20% 
A39B11 4.02 30% 21% 
A39B12 4.11 33% 23% 
A39B13 4.19 35% 26% 
A39B18 4.61 49% 33% 
A39B22 4.95 60% 37% 
A16 1.40   
A16B2 1.57 12% 11% 
A16B3 1.66 18% 15% 
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A16B4 1.74 24% 19% 
A16B5 1.82 30% 23% 
A16B6 1.91 36% 26% 
A16B7 1.99 42% 23% 
A16B9 2.16 54% 35% 
A16B10 2.24 60% 38% 
aDP determined by 1H NMR; bAxBy represents PDMSx-b-PMOXAy; cCalculated from the 
equation fPMOXA = 𝑀𝑛 𝑜𝑓 𝑃𝑀𝑂𝑋𝐴𝑀𝑛 𝑜𝑓 𝑃𝐷𝑀𝑆 ; dCalculated from the equation f ∗ = 𝑀𝑛 𝑜𝑓 𝑃𝑀𝑂𝑋𝐴𝑀𝑛 𝑜𝑓 𝑏𝑙𝑜𝑐𝑘 𝑐𝑜𝑝𝑜𝑙𝑦𝑚𝑒𝑟 .  
 
2.2.2. Preparation and characterization of self-assemblies of PDMS-b-PMOXA. 
2.2.2.1. Critical micelle concentration (CMC) determination of PDMS-b-PMOXA. 
ABPs can self-assemble into various nanostructures in aqueous solution with concentrations 
higher than the CMC. As one of the most important parameters, CMC values are first 
investigated for new ABPs. CMC values of PDMS65-b-PMOXA14 and PDMS65-b-PMOXA32 were 
determined by a surface tension technique with increasing ABPs concentration, ranging from 
3*10-4 to 1*10-2 mg/mL. The determined CMC values are 1*10-3 mg/mL for PDMS65-b-
PMOXA14 and 5.8*10-3 mg/mL for PDMS65-b-PMOXA32, respectively (Figure 19). The CMC 
value of PDMS65-b-PMOXA32 is 5.8 times higher than that of PDMS65-b-PMOXA14 due to a 
longer PMOXA block in PDMS65-b-PMOXA32 than in PDMS65-b-PMOXA14. These CMC values 
are in the same range as reported for other ABPs (0.87*10-3 mg/mL for PEG-ss-PCL,8 8.9*10-3 
mg/mL for PEO-b-HPLys,139 and 17*10-3 mg/mL for PEO-ss-PHMssET 140) 
 
Figure 19. Surface tension experiments of (A) PDMS65-b-PMOXA14 and (B) PDMS65-b-
PMOXA32 aqueous solution in different concentration. 
2. Effect of molecular parameters on the architectures and membrane properties of 3D assemblies of amphiphilic copolymers 
 
28 
 
2.2.2.2. Effect of preparation methods on the architectures of supramolecular 
assemblies of PDMSx-b-PMOXAy. 
The method used for the preparation is one of the most important parameters that can 
influence the final architectures of self-assembled ABPs. Since the co-solvent, film 
rehydration, and electroformation methods are often used to prepare supramolecular 
assemblies of ABPs,66,141 we investigated whether they affected the architecture of 
supramolecular assemblies of the model system PDMS65-b-PMOXA14. The film rehydration 
method involved dissolution of the copolymer (5 mg) in ethanol (2 mL) followed by slow 
evaporation of the solvent until a polymer film formed, which was then dried under high 
vacuum for another 2 h. Then, ddH2O (1 mL) or buffer (1 mL) was added, and the mixture 
was stirred overnight at room temperature. The co-solvent method consisted of dissolution 
of copolymer (1 mg) in ethanol (50 µL), and adding it dropwise to 500 µL ddH2O or 500 µL 
PBS, followed by dialysis against ddH2O or PBS for 24 h with changes of ddH2O or PBS three 
times. Giant unilamellar vesicles (GUVs) were prepared by the electroformation technique 
using the Nanion Vesicle Prep Pro setup (Nanion Technologies, Munich, Germany). 50 µL of 
the polymer solution (4 mg/mL in ethanol) were spread over an ITO-coated glass plate and 
evaporated in a vacuum chamber for at least one hour. With an O-ring, a chamber was 
formed around the polymer film, filled with 100 mM sucrose solution, and closed with a 
second ITO glass plate. GUVs were generated at 25 °C with a frequency of 3.0 Hz and 
amplitude of 2.5 V for three hours. For visualization, a few microliters of the GUV solution 
were stained with Bodipy 630/650, dropped into a microscopy chamber filled with 200 µL of 
buffer (20 mM Hepes, pH 7.4, 50 mM NaCl), and investigated at 20 °C using a confocal laser 
scanning microscope (Zeiss LSM 510-META/ConfoCor 2). Different assemblies were formed 
depending on the preparation method: the co-solvent method produced 20 nm diameter 
micelles (Figure 20A), whereas polymersomes with a 200 nm diameter were obtained by the 
film rehydration method (Figure 20B). The electroformation method induced the formation 
of giant polymersomes with diameters in the range 20 - 50 µm (Figure 20C).  
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Figure 20. TEM micrographs of supramolecular assemblies of PDMS65-b-PMOXA14 produced 
by (A) co-solvent method, (B) film rehydration method and (C) LSM micrographs of 
supramolecular assemblies formed by electroformation technique.  
 
2.2.2.3. Effect of initial copolymer concentration on the architecture of 
supramolecular assemblies of PDMSx-b-PMOXAy. 
PDMS-b-PMOXA ABPs tend to form stable polymersomes by film rehydration and 
electroformation method. However, in order to further use them as nanoreactors, the 
electroformation method was not suitable, due to the very low utilization rate of copolymer 
to form the GUVs. As a result, we investigated the influence of the initial copolymer 
concentration from 0.1 mg/mL to 9 mg/mL on the supramolecular assembly architecture of 
PDMS65-b-PMOXA14 for this preparation method. The TEM results demonstrated that the 
initial concentration had no influence on the morphologies and diameters of the self-
assemblies shown by DLS (Figure 21) and supported by TEM images (Figure 22). 
 
Figure 21. The influence of initial concentration of PDMS65-b-PMOXA14 on self-assembly 
behavior measured by DLS. Left and right insets show representative TEM for 0.1 and 9 
mg/mL respectively.  
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Figure 22. TEM images of morphologies formed by PDMS65-b-PMOXA14 with different initial 
concentration. a. 0.1 mg/mL; b. 0.3 mg/mL; c. 0.5 mg/mL; d. 0.7 mg/mL; e. 0.9 mg/mL; f. 1 
mg/mL; g. 3 mg/mL; h. 5 mg/mL; i. 7 mg/mL; j. 9 mg/mL.  
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2.2.2.4. Effect of content of solution on the architectures of supramolecular 
assemblies of PDMSx-b-PMOXAy. 
The self-assembly behavior of ABPs can also be influenced by the buffer composition, such 
as the presence of salts, pH, or traces of organic solvent.52, 59 To investigate the effect of pH 
on the architectures of the supramolecular assemblies of PDMS65-b-PMOXA14 formed by the 
film rehydration method we used various buffers: tris/HCl (pH = 8.0), PBS (pH = 7.2) and 
acetate (pH = 5.0). As seen by a combination of TEM micrographs and DLS data, pH and salt 
type did not affect the self-assembled supramolecular structures leading to polymersomes 
with around 200 nm diameter in all buffer solutions. In addition, polymersomes exhibited 
storage stability of more than one month at room temperature in each buffer solution 
(Figure 23, 24, 25). We attributed this stability to the neutral hydrophilic block PMOXA, 
which acted as a protecting shell. 17, 142  
 
Figure 23. Hydrodynamic radius and stability of PDMS65-b-PMOXA14 polymersomes in 
Tris/HCl buffer (pH 8.0). Inset: representative TEM image of polymersomes. 
 
 
Figure 24. Hydrodynamic radius and stability of PDMS65-b-PMOXA14 polymersomes in PBS 
buffer (pH 7.2). Inset: representative TEM image of polymersomes. 
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Figure 25. Hydrodynamic radius and stability of PDMS65-b-PMOXA14 polymersomes in 
acetate buffer (pH 5.0). Inset: representative TEM image of polymersomes. 
 
2.2.3. Discussion and analysis of effect of fPMOXA on the 3D assemblies of PDMSx-b-
PMOXAy. 
Three types of phase diagrams were obtained based on the Mn of PDMS and fPMOXA values 
(Figure 26). For the ABP series with 5.0 kDa PDMS (PDMS65), ABPs formed large polymer 
aggregates when the DP of PMOXA was less than 10 (fPMOXA ≤ 16%). The presence of 
aggregates was due to the shorter length of hydrophilic PMOXA block not supporting the 
self-assembly structures.131 However, upon filtration, spherical objects were present in the 
turbid solution of PDMS65-b-PMOXA10 (Figure 26A). The ratio ρ = 0.99 between the radii of 
gyration, Rg, obtained by SLS, and the hydrodynamic radius, RH obtained by DLS indicates 
that these spherical objects are polymersomes (Table 3). An fPMOXA value of 16% represented 
the lowest limitation for polymersomes formation.  
2. Effect of molecular parameters on the architectures and membrane properties of 3D assemblies of amphiphilic copolymers 
 
33 
 
 
Figure 26. Phase diagrams for PDMSx-b-PMOXAy based on the self-assembled structures and 
polymer chemical structure. A: PDMS65-b-PMOXA10-38, B: PDMS39-b-PMOXA6-22, C: PDMS16-b-
PMOXA3-10, D: 3D phase diagram of PDMS65-b-PMOXA10-38, PDMS39-b-PMOXA6-22 and 
PDMS16-b-PMOXA3-10, the three points represent PDMS65-b-PMOXA10, PDMS39-b-PMOXA10 
and PDMS16-b-PMOXA10. 
 
By increasing fPMOXA to 25%, polymersomes with radii ≥ 100 nm, and a very minor fraction of 
micelles were formed (Figure 26A and Figure 27b, c, d). The ρ values, namely the ratio of the 
radius of gyration divided by the hydrodynamic radius, of PDMS65-b-PMOXA12 and PDMS65-b-
PMOXA14 with fPMOXA of 16% and 19%, were 1.07 and 0.91 respectively, indicating the 
formation of hollow-sphere structures (Table 3).143 A further increase in fPMOXA from 25% to 
44% induced a decrease of the polymersomes hydrodynamic radii to < 100 nm, but also 
resulted in increasing amount of micelles (Figure 26A and Figure 27e, f). The ρ value for 
PDMS65-b-PMOXA19 was determined as 0.94 (Table 3), thus proving the formation of 
polymersomes. Further increasing the fPMOXA to 65% induced a change in the architecture of 
the supramolecular assemblies, and a mixture of small micelles and larger spherical particles 
with diameter around 70 nm was observed (Figure 27g, h, i). The aspect of cryo-TEM 
micrograph (Figure 30A, B) is similar to recently reported multicompartment micelles.144,145 
However, the resolution of cryo-TEM prevented a more detailed structural analysis. SAXS 
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was also applied to further characterize the spherical particles formed by PDMS65-b-
PMOXA32 (Figure 31). SAXS data of the weakly scattering polymer solution were fitted by a 
form factor of spherical particles with almost homogenous density. Owing to the weak 
scattering, a more detailed analysis of the inner structure of the spherical object was not 
possible. Therefore, the combined cryo-TEM and SAXS was unable to provide more insight 
into the internal structure of spherical particles (Ø ~ 70 nm). In addition, a smaller ρ value for 
PDMS65-b-PMOXA32 of 0.82 (Table 3) supported the presence of soft spheres, but did not 
give information on the internal structure.146 
 
Figure 27. TEM images of self-assemblies formed by PDMS65-b-PMOXAy. a: PDMS65-b-
PMOXA10 (𝑓𝑃𝑀𝑂𝑋𝐴 = 16% ); b: PDMS65-b-PMOXA10 (𝑓𝑃𝑀𝑂𝑋𝐴 = 16% ) after extrusion; c: 
PDMS65-b-PMOXA12 (𝑓𝑃𝑀𝑂𝑋𝐴 = 20%); d: PDMS65-b-PMOXA14 (𝑓𝑃𝑀𝑂𝑋𝐴 = 24%); e: PDMS65-b-
PMOXA16 (𝑓𝑃𝑀𝑂𝑋𝐴 = 27%); f: PDMS65-b-PMOXA19 (𝑓𝑃𝑀𝑂𝑋𝐴 = 31%); g: PDMS65-b-PMOXA26 
(𝑓𝑃𝑀𝑂𝑋𝐴 = 44%); h: PDMS65-b-PMOXA32 (𝑓𝑃𝑀𝑂𝑋𝐴 = 53%); i: PDMS65-b-PMOXA38 (𝑓𝑃𝑀𝑂𝑋𝐴 =64%). 
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The transition from polymersomes to micelles was observed for ABPs of poly(ethylene 
oxide)-block-poly(N,N-diethylaminoethyl-methacrylate) (PEO-b-PDEAMA), polystyrene-b-
poly(4-vinylpyridine) (PS-b-P4VP), and polystyrene-dendrimer with increasing length of 
hydrophilic blocks.131, 147, 148 In the PS-b-P4VP system, the polymersomes formed in the range 
of fP4VP 13 - 24%, which was similar with the range of fPMOXA for our PDMS-b-PMOXA polymer 
system. The fPMOXA value mainly determined the shape of the polymeric chains, and 
therefore influenced the size and morphologies of the self-assembled structures.149, 55 The 
formation of larger spherical particles is presumably caused by increasing the length of the 
hydrophilic PMOXA, which combines spherical micelles into larger spherical particles.  
The phase diagram of PDMS-b-PMOXA with a 3.1 kDa PDMS (PDMS39) shows a self-assembly 
behavior similar to that of the higher Mn PDMS (for fPMOXA values > 25%). In contrast, this 
series of copolymers did not generate polymersomes with diameter > 100 nm for the whole 
domain of fPMOXA values (Figure 26B). Polymer aggregates were present during the self-
assembly of block copolymers with fPMOXA < 19%, whereas increasing the fPMOXA value to 27% 
induced the formation of mixtures of polymersomes with diameter < 100 nm, spherical 
micelles, and worm-like micelles. (Figure 26B and Figure 28a-e). A further increase in fPMOXA 
to 60% resulted in the formation of a mixture of small micelles and larger spherical micelles. 
(Figure 26B, Figure 28f-g and Figure 30C).  
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Figure 28. TEM images of self-assemblies formed by PDMS39-b-PMOXAy a: PDMS39-b-
PMOXA6 (𝑓𝑃𝑀𝑂𝑋𝐴 = 16%); b: PDMS39-b-PMOXA7 (𝑓𝑃𝑀𝑂𝑋𝐴 = 19%); c: PDMS39-b-PMOXA8 
(𝑓𝑃𝑀𝑂𝑋𝐴 = 22%); d: PDMS39-b-PMOXA9 (𝑓𝑃𝑀𝑂𝑋𝐴 = 24%); e: PDMS39-b-PMOXA10 (𝑓𝑃𝑀𝑂𝑋𝐴 =27%); f: PDMS39-b-PMOXA11 (𝑓𝑃𝑀𝑂𝑋𝐴 = 30%); g: PDMS39-b-PMOXA12 (𝑓𝑃𝑀𝑂𝑋𝐴 = 33%); h: 
PDMS39-b-PMOXA13 (𝑓𝑃𝑀𝑂𝑋𝐴 = 35%); i: PDMS39-b-PMOXA18 (𝑓𝑃𝑀𝑂𝑋𝐴 = 49%); j: PDMS39-b-
PMOXA22 (𝑓𝑃𝑀𝑂𝑋𝐴 = 60%). 
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Figure 29. TEM images of self-assemblies formed by PDMS16-b-PMOXAy a: PDMS16-b-
PMOXA2 (𝑓𝑃𝑀𝑂𝑋𝐴 = 12%); b: PDMS16-b-PMOXA3 (𝑓𝑃𝑀𝑂𝑋𝐴 = 18%); c: PDMS16-b-PMOXA4 
(𝑓𝑃𝑀𝑂𝑋𝐴 = 24%); d: PDMS16-b-PMOXA5 (𝑓𝑃𝑀𝑂𝑋𝐴 = 30%); e: PDMS16-b-PMOXA6 (𝑓𝑃𝑀𝑂𝑋𝐴 =36%); f: PDMS16-b-PMOXA7 (𝑓𝑃𝑀𝑂𝑋𝐴 = 42%); g: PDMS16-b-PMOXA9 (𝑓𝑃𝑀𝑂𝑋𝐴 = 54%); h: 
PDMS16-b-PMOXA10 (𝑓𝑃𝑀𝑂𝑋𝐴 = 60%).  
 
The phase diagram of PDMS-b-PMOXA with 1.4 kDa PDMS showed a completely different 
self-assembly behavior (Figure 26C). For fPMOXA values < 18%, the copolymer was in an 
aggregate phase, while for fPMOXA values in the range 24 - 30%, mixtures of worm-like and 
spherical micelles were obtained (SI, Figure 29b, c). For fPMOXA values of 36 - 60%, only 
spherical micelles with radii around 20 nm were observed (Figure 26C and Figure 29d-h, 
Figure 30D), but with no clustering to generate larger spherical particles. 
Analogous to increasing fPMOXA, increases in f* values for different ABP series resulted in 
changes in the morphologies of the self-assembled structures from larger to smaller 
polymersomes, and finally to a mixture of small micelles and larger spherical particles for the 
first block copolymers series (f* 14 - 39%); from a mixture of polymersomes and wormlike 
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micelles and spherical micelles to the mixture of small micelles and larger spherical particles 
for the second block copolymers series (f* 14 - 37%); from wormlike micelles and spherical 
micelles to spherical micelles for the third block copolymers series (f* 11 - 38%).  
In order to understand the role of the hydrophobic block in determining the architecture of 
the supramolecular assembles, we analyzed the behavior of PDMS65-b-PMOXA10, PDMS39-b-
PMOXA10, and PDMS16-b-PMOXA10 copolymers (Figure 26D). With increasing hydrophobic 
block lengths, the copolymers self-assembled into morphologies starting with spherical 
micelles (for short PDMS length), progressing to a mixture of spherical micelles, wormlike 
micelles, and small polymersomes (for medium PDMS length), and finally to polymersomes 
(for long PDMS length). This self-assembly trend as a function of the hydrophobic domain 
was in agreement with previous reports for poly(ethyleneoxide)-block-poly(γ-methyl-ε-
caprolactone) (PEO-b-PMCL), poly(ethyleneoxide)-block-poly(N,N-
diethylaminoethylmethacrylate) (PEO-b-PDMAEMA), and poly(styrene-block-4-vinylpyridine) 
(PS-b-P4VP) ABPs.131, 143, 147 In order to identify the combined effect of two molecular factors 
(fPMOXA and the Mn of the hydrophobic domains), the self-assembly process was expressed as 
a 3D phase diagram (Figure 26D) for the mean hydrodynamic radii calculated for spherical 
objects formed by self-assembly in solution as function of Mn of the PDMS and fPMOXA. There 
was a specific domain of molecular properties, which supported the formation of 
polymersomes with radii larger than 100 nm: a long hydrophobic block (PDMS65) combined 
with small hydrophilic domains (fPMOXA values < 25%). Polymersome formation was favored 
by adjusting the sizes of the hydrophobic and hydrophilic domains to produce fPMOXA values 
of < 25%. Both molecular properties played a role in the self-assembly process of hollow 
sphere architecture. Once the Mn of hydrophobic block decreased, the hydrodynamic radius 
of spherical objects decreased dramatically, and micelles were the predominant architecture. 
Interestingly, the formation of micelles was independent on the hydrophilic domain (for the 
whole range of fPMOXA we tested) once the hydrophobic block was small enough to prevent 
the formation of polymersomes. For both small hydrophilic and hydrophobic domains 
mixtures of micelles with small radii and worm-like structures were generated. This was due 
to the balance between the hydrophilic and hydrophobic domains not supporting the 
formation of membranes with curvature.50 
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Figure 30. Cryo-TEM images of self-assemblies formed by PDMSx-b-PMOXAy. (A) PDMS65-b-
PMOXA26 ( 𝑓𝑃𝑀𝑂𝑋𝐴 = 44% ), (B) PDMS65-b-PMOXA38 ( 𝑓𝑃𝑀𝑂𝑋𝐴 = 64% ), (C) PDMS39-b-
PMOXA10-22 (𝑓𝑃𝑀𝑂𝑋𝐴 = 30 − 60%) and (D) PDMS16-b-PMOXA5-10 (𝑓𝑃𝑀𝑂𝑋𝐴 = 30 − 60%).  
 
The self-assembly behavior is governed by two factors: the curvature of the membrane, 
which is formed during the self-assembly process, and the intrinsic water solubility of the 
copolymers. First, copolymers with lower fPMOXA induce supramolecular assemblies with 
lower curvature values,134 and are therefore expected to self-assemble into polymersomes. 
Due to the chain segregation occurring from hydrophobic-hydrophilic mismatch, the short 
hydrophilic block is in a stretched conformation, thereby reducing its contribution to an 
additional curvature effect.50, 150 In contrast, copolymers with higher fPMOXA values induce 
supramolecular assemblies with higher curvature. This prevents the formation of 
polymersomes and increases the probability of forming micellar structures, due to higher 
steric repulsion of hydrophilic chains tethered at the interface.151  
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Table 3. Gyration, hydrodynamic radii and resulting ρ-value (ρ = 𝑅𝑔
𝑅ℎ
) of self-assemblies of 
selected PDMS-b-PMOXA ABPs. 
Sample Rg (nm) Rh (nm) ρ (ρ = 𝑅𝑔𝑅ℎ) 
PDMS65-b-PMOXA10 131 132 0.99 
PDMS65-b-PMOXA12 132 123 1.07 
PDMS65-b-PMOXA14 104 115 0.91 
PDMS65-b-PMOXA19 71 75 0.94 
PDMS65-b-PMOXA32 80 98 0.82 
 
 
Figure 31. SAXS patterns (dark blue) and data fits (lighter blue) obtained for the respective 
PDMS65-b-PMOXA32 self-assemblies PBS buffer solution (5 mg/mL). The figure shows the 
scattering curve (dark blue) of “CH4-micelles” (intensity I vs momentum transfer q). The 
lighter blue line is a fit taking into account a spherical particle with a radius of 
r = (315 ± 68) Å. An additional scattering feature from 0.03 - 0.06 Å can be seen. However, it 
is difficult to interpret it in more detail. 
 
In addition, Cryo-TEM micrographs indicated that the membrane thickness increased with 
increasing Mn of the hydrophobic block: PDMS39-b-PMOXA8 polymersomes had a thickness 
of 16.0 ± 1.1 nm, whilst PDMS65-b-PMOXA14 polymersomes had a thickness of 21.3 ± 1.2 nm 
(Figure 32A and 32B). The hydrophilic blocks did not contribute to the membrane thickness 
since they were in a fully hydrated state.  
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Figure 32. Cryo-TEM micrographs of different PDMS-b-PMOXA ABPs supramolecular 
assemblies formed by self-assembly of A: PDMS65-b-PMOXA14, B: PDMS39-b-PMOXA8, C: 
PDMS16-b-PMOXA7. Inset: enlarged view of the membrane thicknesses of PDMS65-b-
PMOXA14 (A) and PDMS39-b-PMOXA8 (B). 
 
2.2.4. Membrane properties of self-assemblies investigated by EPR 
While there are various studies indicating that the thickness of polymersome membranes 
depends on the hydrophobic block, as shown by cryo-TEM micrographs,152 until now, there 
have been no reports on the local flexibility and polarity of polymer membranes. However, 
these are essential factors to take into account when planning to insert membrane proteins 
into polymersome membranes for nanoreactor development. In order to get insight into 
membrane properties, we investigated the local microviscosity and micropolarity by spin 
probe EPR. While the local microviscosity is determined from the rotation correlation time of 
the spin probes, the micropolarity is determined from the hyperfine coupling, and the line-
width of the spin probes inserted in the polymer membranes (in various depths). 
Micropolarity was estimated by measuring the 14N hyperfine coupling constants of nitroxide 
spin probes, and the spectral linewidths (especially the high-field line), known to be strongly 
affected by the local polarity around the nitroxide moiety.153 Although nitroxide spin probes 
are commonly employed to characterize self-assembly behavior in solution and the critical 
micellar concentration for various polymers, a careful selection of spin probes in terms of 
their compatibility with the size and structure of the polymer assembly is necessary. The 
selection aims to avoid the localization of the spin probe inside water pockets that will give 
no information about the self-assembling characteristics.154-156 The hydrophobic spin probes 
5 DSA and 16 DSA were chosen because they are large enough to avoid being trapped in 
small water pockets. In addition, they are expected to be compatible with the hydrophobic 
PDMS block and avoid electrostatic repulsions. First, the EPR spectra of both spin-probes 
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were analysed at temperatures ranging from 150 to 320 K in 0.1 M NaOH and 20% glycol to 
voids line-broadening caused by formation of water crystalline structure. They consist of an 
isotropic triplet, which indicates rapid tumbling, and hence no aggregation (Figure 33). The 
14N coupling constants aN have values in the range 15.8 - 16.0 G, which are similar to those 
reported in the literature (15.8 G for 5 DSA in 0.1 M NaOH,157 and 15.9 for 16 DSA in 0.1 M 
NaOH respectively).158 At 100 K the EPR spectrum of 5 DSA in pure water is a broad singlet, 
due to phase separation and spin-spin interactions. Therefore the hyperfine coupling 
constant 2Azz cannot be determined. However, addition of glycol (20%), resulted in an 
anisotropic EPR spectra typical of rigid molecules in a random orientation, and revealed 2Azz 
values of 71.3 G for 5 DSA and 72.1 G for 16 DSA (Figure 33). 
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Figure 33. Rigid limit and fast motional spectra of 5 DSA and 16 DSA in 0.1 M NaOH (300 K) 
and 20% glycol at temperatures ranging from 150 K to 260 K and 300 K, respectively. 
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Second, the mobility of both nitroxide spin probes in PDMS65-b-PMOXAy membranes was 
studied in two situations: i. when entrapped during the self-assembly process of 
polymersome formation, and ii. when added pre-assembled polymersomes. 
i. The spectra of 5 DSA entrapped during the self-assembly process of PDMS65-b-PMOXA12, 
PDMS65-b-PMOXA14, PDMS65-b-PMOXA19 and PDMS65-b-PMOXA32 are significantly different 
from that of free 5 DSA (Figure 34A, 35). For PDMS65-b-PMOXA12, PDMS65-b-PMOXA14 and 
PDMS65-b-PMOXA32 at temperatures varying from 150 K to 290 K, a broad EPR signal, typical 
of slow-motion regime of aggregated spin-probes, was obtained. At higher temperatures, up 
to 320 K, both an isotropic triplet (characteristic for free rotation of the spin probe), and a 
broad signal (due to hindered rotation) are detected. The isotropic triplet has aN values for 
PDMS65-b-PMOXA12 and PDMS65-b-PMOXA14 polymersomes of 15.3 G and 15.6 G, 
respectively, which differs slightly from that of free 5 DSA. aN values for PDMS65-b-PMOXA32 
assemblies are similar to that of the free 5 DSA (15.9 G). aN values indicate that the spin-
probes face two different environments which depend on the copolymer molecular 
properties. The smaller aN values for PDMS65-PMOXA12 and PDMS65-b-PMOXA14 
polymersomes are consistent with a more hydrophobic environment and indicate the 
insertion of the spin probe in the siloxane layer.155 The similar aN value PDMS65-b-PMOXA32 
as that obtained in pure water indicates that the spin probe is located at the hydrophilic 
interface of the PMOXA layer. The broad EPR signal superposed on an isotropic triplet 
spectrum at the higher temperatures indicates either an aggregation of the spin probe due 
to its insertion into the spherical particles, or a limited rotation, due to a high density of the 
hydrophobic domain.  
With PDMS65-b-PMOXA19 the behavior of the spin probe was completely different from that 
described above (Figure 35). In the temperature range 150 - 290 K, typical rigid limit spectra 
were obtained, with 2Azz values of 70.2 G. Well resolved spectra, and smaller value for 2Azz 
compared to that detected for 5 DSA in glycol (71.3 G) indicate that there is no aggregation, 
normally accompany of spin probe insertion in hydrophobic region of membranes. This 
indicates that the spin probe was located in the PDMS domain, which had a higher flexibility 
than that observed inside the copolymer micelles for the other three types of polymer. At 
290 K a two component EPR spectrum was obtained: an anisotropic component with a value 
of 51 G for 2Azz, and a broad signal similar to that described in the literature for a spin probe 
in a lipid bilayer in the presence of sodium dodecyl sulfate.159 The significantly smaller value 
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for 2AZZ is obtained because of motion that is not sufficient to produce an isotropic spectrum. 
The broad spectrum indicates slow tumbling of the spin probe because of the high viscosity 
of the microenviroment in the copolymer micelles. In addition, the presence of a two 
component signal suggests that the spin probe was incorporated into two different types of 
architectures (micelles and polymersomes membranes, or micelles and spherical particles). 
When the temperature was increased to 320 K, an isotropic triplet was observed superposed 
on a broad signal, similar to the spectra of the other copolymer polymersomes. For PDMS65-
b-PMOXA19 polymersomes, the isotropic component was less well defined than for the other 
three copolymers. A rough estimation of aN value of 15.7 G was estimated, which is higher 
than for PDMS65-b-PMOXA14 and smaller than that for PDMS65-b-PMOXA32. With increasing 
PMOXA length, the spin probe is located much closer to the PMOXA than the PDMS 
hydrophobic domain. This suggests that PDMS65-b-PMOXA32 diblock polymers arrange in 
hydrophilic-hydrophobic-hydrophilic membrane architecture. The use of 16 DSA as a spin-
probe, which is known to penetrate much deeper into hydrophobic layers, indicated a 
similar behaviour involving insertion in the hydrophobic domain of polymer membrane of 
PDMS65-b-PMOXA12, but for PDMS65-b-PMOXA14 and PDMS65-b-PMOXA32 the spin-probe was 
only present at the interface between PDMS and PMOXA domains (Figure 35). 
 
Figure 34. Temperature dependence of the EPR spectra of A) 5 DSA entrapped inside 
polymeric membrane during polymersome preparation by the film rehydration method and 
B) 5 DSA mixed with preformed polymersome solutions. 
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Figure 35. Rigid limit and fast motional spectra of 5 DSA encapsulated in PDMS65-b-PMOXA14, 
PDMS65-b-PMOXA19, PDMS65-b-PMOXA32 and 5 DSA and 16 DSA inserted in preformed 
structures. 
 
ii. When the 5 DSA spin probe was mixed with preformed polymersome solutions, its 
behaviour was completely different from that observed for incorporation during the self-
assembly process. At temperatures < 280 K anisotropic EPR spectra typical of slow motion 
were observed with solutions of PDMS65-b-PMOXA12, PDMS65-b-PMOXA14 and PDMS65-b-
PMOXA32 (Figure 34B, 35). 2Azz values calculated from spectra recorded at 150 K (69.2 G for 
both PDMS65-b-PMOXA12 and PDMS65-b-PMOXA14 polymersomes) are slightly smaller than 
those recorded in glycerol (71.2 G), indicating that the spin probe penetrated the 
hydrophobic domain. No resolved anisotropic components were observed for PDMS65-b-
PMOXA32 spherical particles, probably due to the aggregation of the spin probe. For PDMS65-
b-PMOXA19 polymersomes, the value of 70.3 G for 2Azz at 150 K is much closer to the value 
for 5 DSA in glycerol, and suggests that the spin probe is present at the interface between 
the hydrophobic and hydrophilic domain, with the nitroxide group oriented toward the 
PMOXA domain. At 270 K the EPR spectrum contained three components; a rigid-limit 
spectrum, an isotropic spectrum, and a broad anisotropic spectrum. This complex EPR 
spectrum is probably the consequence of insertion of the spin probe into two different 
structures micelles and polymersomes/soft particles. 
At temperature ≥ 290 K three-peak EPR spectra, characteristic of fast motional averaging 
were observed with all copolymer 3D assemblies. The aN values of 15.7-15.9 G at 300 K 
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indicate localization of the nitroxide group of the spin probe in a hydrophilic, polar 
environment, similar to that in glycol. To get more insight into the dynamics of the spin 
probe inside the hydrophilic domain of particles, we calculated the rotation correlation time 
of 5 DSA spin probe.160 The rotation correlation time of 0.77 ns for 5 DSA in NaOH (0.72 
ns)158 increased to 2.7 ns in PDMS65-b-PMOXA12 polymersomes, 1.18 ns in PDMS65-b-
PMOXA14 polymersomes, 0.98 ns in PDMS65-b-PMOXA19 polymersomes, and 0.86 ns in 
PDMS65-b-PMOXA32 preformed structures. The increase of the rotation time and the 
broading of the high-field peak of EPR spectra, caused by an increase of the rotation 
correlation time, indicate the localization of the spin probe in a more viscous environment, 
such as the PMOXA hydrophilic layer (PDMS65-b-PMOXA12 to PDMS65-b-PMOXA19 
polymersomes). These values are comparable to that determined for 5 DSA in 20% glycerol 
solution (1.2 ns), characterized by an increased viscosity. With PDMS65-b-PMOXA32, the 
rotation correlation time is closer to that in water (0.77 ns) and indicates that the spin probe 
is inserted into the PDMS domain with the nitroxide group oriented toward aqueous 
medium. 
The rotation correlation time values decreasing to that for 5 DSA in water correlated with 
higher 2Azz and aN values, and shows that the PMOXA layer serves as a protecting layer for 
the hydrophobic domain. The effect is more pronounced with the increase of the hydrophilic 
block thickness. 
EPR results provide a deep insight into the flexibility of polymer membranes with a 
hydrophobic dense domain of PDMS, which hinders the free rotation of the spin probe and 
induces broadening even at high temperatures, and the more elastic hydrophilic PMOXA 
layers. The different flexibility and the nature of each block induces a change in aN values 
(related to the polarity), and of the slow motion broad signal of 5 DSA entrapped in 
membranes. The values of EPR parameters indicate clearly the spin probe insertion in the 
rigid PDMS layer. Moreover, the combination of a change in correlation time with no change 
in aN value for 5 DSA in the presence of preformed PDMS65-b-PMOXA12, PDMS65-b-PMOXA14 
and PDMS65-b-PMOXA32 3D assemblies, clearly suggests insertion of the spin probe only 
inside the PMOXA hydrophilic layer. With an increase in the PMOXA block length from 
PDMS65-b-PMOXA12 to PDMS65-b-PMOXA19, and PDMS65-b-PMOXA32 the flexibility of the 
PMOXA hydrophilic domain was reduced, and induced localization of the spin probe in the 
PMOXA domain when added to the preformed 3D assemblies. Thus the hydrophilic region 
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exposed at the surface of preformed 3D assemblies acts as a protective layer for the 
hydrophobic (PDMS) domain, and accessibility to the PDMS domain decreases with 
increasing PMOXA domain length. The shielding property of PMOXA domain is important for 
developing medical applications, where interactions with biological molecules should be 
avoided (to increase the circulation times). This represents the first evidence of a significant 
change in the behavior of the membrane as a function of the hydrophilic block length. The 
difference between the hyperfine coupling of the spin probe entrapped during the formation 
of supramolecular assemblies from PDMS65-b-PMOXA12, PDMS65-b-PMOXA14, PDMS65-b-
PMOXA19 to PDMS65-b-PMOXA32 can be explained by the transition from polymersomes, to 
mixtures of micelles and smaller polymersomes, and finally a mixture of micelles and 
spherical particles, in agreement with the LS and Cryo-TEM data.  
Detergents are needed for extracting membrane proteins from biological membranes and 
mediating their solubility in aqueous solutions, and are important for their purification and 
stabilization.161 Since channel proteins are usually inserted into polymersome membranes to 
render them permeable, the nanoreactor solutions might contain detergent molecules.81 In 
order to check the influence of detergent on the permeability and fluidity of polymersomes 
membranes, the effect of adding 1% detergent (Triton X-100), a concentration reported to 
destroy lipid vesicles,162 on the depth of penetration of the 5 DSA spin probe inside polymer 
membranes was investigated. The EPR parameters of 5 DSA obtained in polymersome 
solution after addition of detergent with those for 5 DSA in the presence of the detergent in 
distilled water were analysed. At 150 K the EPR spectra were anisotropic, with 2Azz values of 
66.2 G for free 5 DSA and 69.1-69.3 G for 5 DSA in preformed polymersome solutions of 
PDMS65-b-PMOXA12, PDMS65-b-PMOXA14 polymers, respectively (Figure. 36). At 
temperatures ranging from 290 K (Figure. 36) to 320 K, the EPR spectra of free 5 DSA in 
detergent showed broad three lines isotropic spectra with aN of 14.8 G, which indicate a 
slow tumbling of the spin probe due to the higher viscosity inside detergent micelles.159 
When polymersomes were mixed with detergent, the spectra were similar to that described 
for a spin probe location in a lipid bilayer in the presence of sodium dodecyl sulfate (with an 
anisotropic broad component and an isotropic one).163 Therefore in this situation, the 
nitroxide spin probe is immobilized and cannot freely rotate.  
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Figure 36. Rigid limit and fast motional EPR-spectra of 5 DSA inserted in preformed 
polymersomes treated with 1% Triton X-100, at 100 K, respectively 300 K. 
 
At temperatures above 290 K, aN values were 14.6 G for 5 DSA in detergent solution and 
16.1-16.2 G in preformed polymersome solutions while in the presence of detergent. This 
indicates that the spin probe was inside the PDMS layer, which is denser and less flexible 
than the detergent. In addition, it suggests that the nitroxide group is oriented toward the 
PMOXA domain. The higher values of aN exclude the possibility of nitroxide location in 
micelles, as observed for the PDMS65-b-PMOXA19 polymer. In order to check if the detergent 
treatment did not influence the integrity of the PDMS65-b-PMOXA12 and PDMS65-b-PMOXA14 
membranes, TEM micrographs, and DLS analysis were performed as well. After Triton 
treatment, spherically shaped structures were preserved, as shown by TEM micrographs 
(Figure 37). In addition, Rh value of 120 nm for PDMS65-b-PMOXA12 and 112 nm for PDMS65-
b-PMOXA14 polymersomes were determined by DLS.  
 
Figure 37. TEM micrographs of (A) PDMS65-b-PMOXA12 and (B) PDMS65-b-PMOXA14 
polymersomes formed by self-assembly of block copolymers in PBS in presence of 5 DSA 
with 1% Triton X-100. 
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2.3. Conclusions 
In order to study the influence of molecular parameters and preparation methods on the 
architecture of supramolecular assemblies generated by self-assembly, we have synthesized 
a library of three PDMS-b-PMOXA ABPs: PDMS65-b-PMOXA10-38, PDMS39-b-PMOXA6-22, and 
PDMS16-b-PMOXA3-10. 3D phase diagrams indicate that both PDMS and PMOXA domains play 
a key role in the self-assembly process in aqueous solutions. For a PDMS block length of 5.0 
kDa, increasing the length of hydrophilic PMOXA blocks lead to changes in the self-assembly 
architectures from polymer aggregates, polymersomes with radii > 100 nm, to a mixture of 
micelles and polymersomes with radii around 50 nm, and finally to a mixture of micelles and 
spherical particles. In contrast, decreasing the Mn of hydrophobic domain prevented the 
formation of polymersomes but lead to micelles. For copolymers with the same 
hydrophilic/hydrophobic ratio, the Mn of the hydrophobic block representd the key factor 
that governed the self-assembly process. The polymersome membrane presents an internal 
structure with a dense hydrophobic middle layer, and two more elastic hydrophilic PMOXA 
inner and outer domains. The outer PMOXA layer has a protective role and prevented the 
penetration of spin probes into the polymersome membrane before detergent treatment 
even if they were highly hydrophobic. This protection effect was enhanced by increasing the 
PMOXA block, and indicated low membrane fluidity, which is known to correlate with a high 
mechanical stability. Destabilization of the membrane by 1% Triton X-100 resulted in easier 
penetration of the spin probes into the siloxane membrane. However, the structure of 
polymersomes was preserved upon treatment with detergent, and only the permeability of 
the membrane for hydrophobic cargo was increased. To the best of our knowledge, this 
represents the first characterization of the intrinsic aspects of a membrane generated by 
self-assembling amphiphilic block copolymers, and provides insight into the finer details 
regarding the flexibility and permeability of polymersomes. Thus, appropriate selection of 
molecular parameters and preparation method are essential for generating polymersomes 
with desired membrane properties, for example the insertion of membrane proteins or 
engineering artificial organelles. 
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The manuscript about this work is being writing and will be submitted.   
3.1 Introduction 
Nanocarriers are nanosized materials with a large surface area and inner volume, which can 
carry multiple small functional molecules encapsulated inside their cavity or on their 
surface.164 Due to their ability of loading diverse molecules, nanocarriers are applied as 
potential platforms for disease therapy,165, 166 imaging,167 biomolecules detection,168 
sensoring,169 and antimicrobial,89, 170 application. Benefitting from the development of 
nanotechnology, nanocarriers are prepared by metal-organic frameworks,167 functionalized 
inorganic nanoparticles,109, 171 cavity proteins,169 metal nanoparticles,168, 172, 173dendrimers,174 
and self-assemblies of ABPs..95, 132, 175, 176 During the self-assembly process of ABPs in 
aqueous solution, hydrophobic molecules such as anticancer drugs177 or quantum dots80 can 
be encapsulated into the hydrophobic domains of the self-assembled structures. All of these 
factors have led self-assembled ABPs to be a leading field of nanocarriers research.178, 179  
The functional properties of ABPs and their self-assembled nanostructures are determined 
by the nature and chemical properties of their constituting polymer blocks, and their 
functional groups.70, 72, 180 By using polyesters such as PCL, PLA, or polypeptides as 
hydrophobic polymer building blocks, the formed nanostructures can be endowed with 
biodegradability and biocompatibility, which is favored if intended for bio-applications.181-184 
PEG and PMOXA two often used as hydrophilic polymer building blocks due to their 
biocompatibility as well as ability to limit interaction with blood components, toxicity, and 
first pass clearance.17 Recently, results demonstrated that PMOXA show a higher chemical 
stability compared to PEG upon exposure to physiological conditions,185 and PMOXA 
decorated liposomes also showed higher circulation time in blood.186 The reason why 
PMOXA is less prone to degradation than PEG is that N-vicinal C−H bonds are less polarized 
than O-vicinal C−H bonds and are known to be stable against biological degradation.187,188,189 
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Self-assemblies of ABPs with stimuli-responsiveness: pH,68 temperature,190 irradiated light,191 
enzyme127, 180 or a combination thereof,192 are some of the most promising candidates in 
drug delivery research and application. Due to their stimuli-responsiveness, these self-
assemblies can disassemble rapidly and release their encapsulated cargoes upon a desired 
stimuli in short time, which can maximize therapeutic efficiency.71, 72 Responsive functional 
groups can be introduced on one of the ABP building blocks the side chains, or as the linker 
between hydrophobic and hydrophilic blocks.193-195 Among all stimuli-responsive functional 
groups, redox-responsive disulfide bonds (-SS-) which can be cleaved by reducing agents,196 
are one of the most interesting responsive groups. This is due to the existence of a large 
difference in reducing potential between extracellular fluids and the intracellular 
environment (2-20 µM and 0.5-10 mM of glutathione (GSH) respectively ).197 Two examples 
of nanoparticles self-assembled by ABPs containing disulfide bonds are dextran-SS-poly(ε-
caprolactone) and poly(ethylene glycol)-SS-poly(methacrylate). Both nanoparticles released 
their encapsulated cargoes upon addition of the reducing agents dithiothreitol (DTT) or GSH 
faster than dextran-block-poly(ε-caprolactone) and poly(ethylene glycol)-block-
poly(methacrylate) without redox responsive disulfide groups.77,140  
Here, we report the synthesis of a new reduction responsive ABP, poly(2-methyl-
2oxazoline)-graft(ss)-poly(ε-caprolactone) (PMOXA-graft(ss)-PCL), composed of hydrophilic 
PMOXA and hydrophobic biodegradable PCL with grafted molecular structure, in which the 
reduction responsive disulfide group acts as the linker between PMOXA and PCL. The reason 
and motivation of synthesizing PMOXA-graft(ss)-PCL with graft molecular structure are i) the 
graft hydrophilic PMOXA can provide more steric hindrance on the surface of the self-
assemblies which is possible to keep stable self-assembled nanostructure; ii) the polymers 
with graft structure are easier to obtained comparing with linear ones through two blocks 
coupling synthesis procedure.  Technologies of 1H NMR, FTIR, and GPC were applied to 
analyze the chemical structures and parameters of PMOXA-graft(ss)-PCL. DLS and TEM were 
used to characterized the self-assembly nanostructures of PMOXA-graft(ss)-PCL in aqueous 
solution. In addition, the reduction responsive behavior of self-assembled nanostructures is 
characterized by DLS, FCS, and TEM. Finally, cell culture experiments to determine the 
toxicity of PMOXA-graft(ss)-PCL and DOX loaded self-assembly nanostructures were carried 
out in Hela cells.  
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3.2. Results and discussion 
3.2.1. Synthesis and characterization of PMOXA-SAc, PMOXA-SH, PCL-co-PBCL, 
PCL-co-PCCL and PMOXA-graft(ss)-PCL copolymer 
3.2.1.1. The synthesis scheme of PMOXA-SAc, PMOXA-SH, PCL-co-PBCL, PCL-co-
PCCL and PMOXA-graft(ss)-PCL copolymer 
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Scheme 9. The synthetic route for PMOXA-SH, PCL-co-PPCL and PMOXA-graft(ss)-PCL.a  
a Reagents and conditions: (i) methyl trifluoromethanesulfonate, acetonitrile, 80 °C for 24 h 
under argon; (ii) potassium thioacetate, RT for 24 h under argon; (iii) triphenylphosphine, 
anhydrous MeOH, RT for 48 h under argon; (iv) anhydrous EtOH, Tin(II) 2-ethylhexanoate, 
toluene, 110 °C for 24 h under argon; (v) Pd/C (10 wt. %), ethyl acetate, RT for 42 h under 
hydrogen; (vi) 2-pyridylthiol cysteamine hydrochloride, N,N'-dicyclohexylcarbodiimide, 4-
dimethylaminopyridine, triethylamine, DCM, RT for 60 h under argon; (vii) acetic acid, DMF, 
RT for 60 h under argon.  
 
3.2.1.2. Characterization of PMOXA-SAc, PMOXA-SH, PCL-co-PBCL, PCL-co-PCCL and 
PMOXA-graft(ss)-PCL copolymer 
Synthesis of thiolated PMOXA (PMOXA-SH). Living ROP of 2-methyl-2-oxazoline was 
initiated by methyl trifluoromethanesulfonate in acetonitrile.17 After the polymerization, 
potassium thioacetate was used in excess to quench the polymerization and introduce the 
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thiolacetate group to synthesize PMOXA-SAc. The appearance of peaks at δ 2.34 ppm and 
2.94 ppm were characteristic of the protons of methyl group of thiolacetate and methylene 
group next to the thiol group (Figure 38A).198 The PMOXA-SAc was further reduced by PPh3 
in anhydrous MeOH to synthesize PMOXA-SH. The disappearance of the peaks at δ 2.34 ppm 
and appearance of a peak at δ 2.94 ppm demonstrated the successful reduction and 
synthesis of PMOXA-SH (Figure 38B). Fast operation was necessary to avoid disulfide 
formation between two thiol ended PMOXA polymers (PMOXA-SH) during the purification. 
 
Figure 38. 1H NMR spectrums of PMOXA-SAc (A) and PMOXA-SH (B) in d6-DMSO. 
 
Synthesis of poly(ε-caprolactone)-co-poly(α-pyridyldisulfide-ε-caprolactone) (PCL-co-PPCL). 
The monomer α-benzyl carboxylate-ε-caprolactone was synthesized according to a previous 
published method.199 Ethanol was used to initiate the copolymerization of monomer ε-
caprolactone and α-benzyl carboxylate-ε-caprolactone with varying molar ratios in toluene 
at 110 °C to synthesize PCL-co-PBCL with a ≥ 80% yield. The appearance of the characteristic 
peaks of benzyl carboxylate group protons (δ 5.23 ppm and 7.26 ppm) demonstrated 
successful copolymerization of ε-caprolactone and α-benzyl carboxylate-ε-caprolactone 
(Figure 39A). The block ratio of PCL-co-PBCL could be calculated by integration of the signals 
at δ 5.23 ppm (methylene protons on benzyl in α-benzyl carboxylate-ε-caprolactone units), δ 
3.33 ppm (methylene protons on ε-caprolactone units) and δ 1.19 ppm (the end methyl 
group). The corresponding Mns determined from 1H NMR of two PCL-co-PBCLs were 33.4 
KDa and 15.2 KDa respectively, while the values determined by GPC were 40 KDa and 13 KDa 
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respectively (Table 4). The PDIs of the two synthesized PCL-co-PBCL samples were 1.5 and 
2.0 (Table 4). Subsequently, PCL-co-PBCL was reduced by Pd/C at RT under hydrogen to 
synthesize the PCL-co-PCCL. The disappearance of the characteristic peaks for methylene 
protons near the phenyl ring at 5.23 ppm and for phenyl ring protons 7.26 ppm 
demonstrated that the benzyl alcohol was successfully eliminated (Figure 39B). Finally, the 
PCL-co-PCCL reacted with 2-pyridylthio cysteamine hydrochloride in the presence of DCC to 
yield PCL-co-PPCL. The appearance of new peaks corresponding to methylene protons next 
to the disulfide group (δ 2.93 ppm) and pyridyl group protons (δ 7.0-8.6 ppm) proved the 
successful esterification and synthesis of PCL-co-PPCL (Figure 39C).  
Table 4. Chemical parameters of PCL-co-PBCLs and PMOXA-graft(ss)-PCLs . 
Samples 
 
 
1H NMR 
 
GPC 
Block ratio 
Mn 
(KDa) 
f(PMOXA)a 
Mw 
(KDa) 
Mn (KDa) PDI 
PCL-b-PBCL 1 264:13 33.4  40000 19.4 2.0 
PCL-b-PBCL 2 126:3 15.2  13000 19.7 1.50 
PMOXA-graft(ss)-PCL2 88:238 34.8 22% 22300 13.0 1.72 
PMOXA-graft(ss)-PCL1 127:165 30.0 36% 18400 13.3 1.38 
PMOXA-graft(ss)-PCL3 135:135 27.0 43% ~ ~ ~ 
a The values of f(PMOXA) were calculated by the equation 𝑀𝑛 𝑜𝑓 𝑃𝑀𝑂𝑋𝐴𝑀𝑛 𝑜𝑓 𝑤ℎ𝑜𝑙𝑒 𝑐𝑜𝑝𝑜𝑙𝑦𝑚𝑒𝑟. 
 
 
Figure 39. 1H NMR spectra of PCL-co-PBCL (A), PCL-co-PCCL (B) and PCL-co-PPCL (C) in CDCl3. 
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Synthesis of poly(2-methyl-2-oxazoline)-graft(ss)-poly(ε-caprolactone) (PMOXA-graft(ss)-
PCL).  
PMOXA-graft(ss)-PCL was synthesized through the thiol-disulfide exchange reaction between 
PMOXA-SH and PCL-PPCL in the presence of a catalytic amount of acetic acid.8 The final 
product was purified by precipitation in cold MeOH in order to remove the unreacted 
PMOXA-SH. The appearance of the proton signals at f, g corresponding to PMOXA and c, d, e, 
f corresponding to PCL in Figure 40 proving the successful synthesis of PMOXA-graft(ss)-PCL. 
The h peak (δ 2.84 ppm) corresponds to the protons on the carbon next to the disulfide, 
which also proves the successful formation of the disulfide group. FT-IR was also used to 
characterize the chemical structure (Figure 41). The absorbance bands at 1720 cm-1 and 
1160 cm-1 in the FT-IR spectrum of PMOXA-graft(ss)-PCL, assigned to stretching vibration of 
C=O and C-O on PCL, and 1724 cm-1 due to the stretching vibration of C=O on PMOXA, 
indicate the synthesis of PMOXA-graft(ss)-PCL copolymers. Three PMOXA-graft(ss)-PCL 
copolymers with different molecular structures and Mn varying from 27 KDa to 34.8 KDa and 
PMOXA fraction (f(PMOXA) ) from 22% to 43% were synthesized. The PDIs of the first two 
PMOXA-graft(ss)-PCLs were 1.72 and 1.38. However, due to insolubility of PMOXA-graft(ss)-
PCL 3 in THF, the GPC could not be recorded (Table 4). The Mn of PMOXA-graft(ss)-PCL 1 and 
PMOXA-graft(ss)-PCL 2 determined from 1H NMR were higher than from GPC, which might 
be caused by the grafted structure of the copolymer.8  
 
Figure 40. The 1H NMR spectrum of PMOXA-graft(ss)-PCL copolymer in CDCl3. 
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Figure 41. The FT-IR spectrums of PCL-co-PBCL (A), PMOXA-SH (B) and PMOXA-graft(ss)-PCL 
(C). 
 
Synthesis of poly(2-methyl-2-oxazoline)-block-poly(ε-caprolactone) (PMOXA-b-PCL) 
PMOXA-OH with Mn 7650 (70 mg) was first dissolved into freshly distilled ε-caprolactone (2 
mL). After Tin(II) 2-ethylhexanoate (3 µL) was added, the reaction was carried out at 110 °C 
for 30 min. After cooling down the reaction mixture to RT, PMOXA-b-PCL was dissolved in 
DCM and precipitated twice into diethyl ether in order to purify the final product. PMOXA-b-
PCL is being used as a control ABP. The peaks of Ha and Hb corresponding to PMOXA and Hc, 
Hd, He and Hf corresponding to PCL 1H NMR spectrum in Figure 42 demonstrated the right 
structures of PMOXA-b-PCL.  
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Scheme 9. The synthetic route for PMOXA-b-PCL.a 
a Reagents and conditions: 1. methyl trifluoromethanesulfonate, acetonitrile, 80 °C for 24 h 
under argon; 2. KOH/MeOH solution (0.5 M), RT for 24 h; 3. ε-caprolactone, Tin(II) 2-
ethylhexanoate, 110 °C for 0.5 h under argon. 
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Figure 42. The 1H NMR spectrum of PMOXA-b-PCL in CDCl3. 
 
3.2.2. Preparation and characterization of PMOXA-graft(ss)-PCL self-assemblies. 
PMOXA-graft(ss)-PCL self-assemblies of were prepared by the solvent exchange method.144 
The diameters of the self-assemblies ranged from 27 nm to 51 nm with a narrow PDI of 0.09-
0.18 according to DLS measurements (Figure 43D). Interestingly, the average diameter of 
self-assemblies decreased with the increase of hydrophilic PMOXA content from 22% to 43% 
(Figure 43D). The decrease can be attributed to a higher interfacial curvature value 
corresponding to the larger hydrophilic block size. The smaller diameter of self-assembled 
nanostructures is correlated with a higher interfacial curvature values.50, 65 From the TEM 
images and DLS results, we can conclude that the self-assemblies are nanoparticles. The 
CMC was measured using pyrene as a fluorescence probe in PBS buffer.200-202 CMC values of 
these three PMOXA-graft(ss)-PCL samples were between 0.05*10-3 - 0.29*10-3 mg/mL 
(Figure 44). In addition, the CMC values increased with the increasing content of hydrophilic 
PMOXA (f(PMOXA)), which was caused by the enhancement of its hydrophilic properties.61 
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Figure 43. Morphologies of nanoparticles formed by PMOXA-graft(ss)-PCLs imaged by TEM 
and diameters measured by DLS. (A) Nanoparticles formed by PMOXA-graft(SS)-PCL 1; (B) 
nanoparticles formed by PMOXA-graft(SS)-PCL 2; (C) nanoparticles formed by PMOXA-
graft(SS)-PCL 3; (D) diameters and distribution of nanoparticles measured by DLS.  
 
 
Figure 44. The fluorescence intensity ratio I383/I372 of pyrene as a function of PMOXA-
graft()ss)-PCL copolymers concentration. The intersection is the value of CMC. (A) PMOXA-
graft(ss)-PCL 2; (B) PMOXA-graft(ss)-PCL 1 and (C) PMOXA-graft(ss)-PCL 3. 
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3.2.3. Reduction responsive properties of PMOXA-graft(ss)-PCLs and their self-
assemblies. 
DLS was used to investigate the reductive properties of PMOXA-graft(ss)-PCL 1 self-
assembled nanoparticles addition of the reducing agent DTT (10 mM) in PBS. DLS 
demonstrated by that 13 minutes after adding DTT, the diameter of the nanoparticles 
changed from 32 nm to 85 nm. After 47 minutes, the diameter of nanoparticle increased to 
2274 nm yielding a very turbid solution (figure 45 and Figure 46B). After 4 h, only white, 
macroscopic aggregates were observed (Figure 46C).  
After filtering and washing the precipitate with MeOH, 1H NMR spectrum was recorded 
showing only the proton signals characteristic of PCL – no peaks from the hydrophilic 
PMOXA were found – proving that the white precipitate was only hydrophobic PCL (Figure 
47). These results clearly indicated that disulfide between PMOXA and PCL was reduced by 
DTT and it led to the disintegration of the nanoparticles. Without DTT, the nanoparticles 
were stable for 24 h without changing their diameter and PDI (Figure 45). Additionally, TEM 
results proved the nanoparticle structure is stable at 37 °C for 48 h. However, in presence of 
DTT, no nanoparticles can be identified in TEM images (Figure 48B).  
 
Figure 45. Changes in the diameter of nanoparticles formed by PMOXA-graft(SS)-PCL 1 in 
response to 10 mM DTT over time measured by DLS. 
 
3. Reduction responsive amphiphilic PMOXA-graft(ss)-PCL copolymers synthesis and their potential application as smart nanocarriers 
 
61 
 
 
Figure 46. Digital imagines of nanoparticle solutions formed by PMOXA-graft(ss)-PCL 1 
(1mg/mL) after DTT (final concentration 10 mM) treatment. (A) 13 minutes after DTT was 
added; (B) 47 minutes after DTT was added and (C) 4 h after DTT was added.  
 
 
Figure 47. The 1H NMR spectrums: (A) PMOXA-graft(ss)-PCL 1; (B) the white precipitation in 
the nanoparticles solution after being treated with DTT (10 mM).  
 
 
Figure 48. (A) TEM image of PMOXA-graft(ss)-PCL 1 nanoparticles in PBS at 37 °C for 48 h. (B) 
TEM image of PMOXA-graft(ss)-PCL 1 nanoparticles in PBS containing DTT (10 mM) at 37 °C 
for 48 h.  
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3.2.4. Triggered release of hydrophobic molecules from reduction responsive 
nanoparticles 
Fluorescence correlation spectroscopy (FCS) was used to follow the disintegration of 
reduction responsive nanoparticles and the release of a model hydrophobic dye. By 
following the diffusion times of fluorescent molecules it is possible to determine whether 
the dye is encapsulated or freely diffusing. Therefore, a stable hydrophobic fluorophore 
(BODIPY 630) was encapsulated into nanoparticles formed by PMOXA-graft(ss)-PCL and 
PMOXA-b-PCL and time series of FCS curves were recorded in the presence or absence of the 
reducing agent DTT (Figure 49A). In case of reduction responsive nanoparticles (PMOXA-
graft(ss)-PCL) in the presence of DTT, the free dye population increased over time, reaching 
more than 90% free dye after 1.5 h. Without DTT or nanoparticles without reduction 
responsibility (PMOXA-b-PCL), the additional DTT did not result in any free dye population in 
the FCS curves after 24 h. By determining hydrodynamic diameters of nanoparticles from 
nanoparticle diffusion time in Figure 49B, the changing bigger trend of diameter was the 
same with DLS measurements in Figure 45. Rapidly after addition of DTT, the diameter of 
nanoparticle and the percentage of free dye population increased. This can be explained by 
a loss of PMOXA – due to reduction-triggered cleavage of PMOXA from the copolymer and 
subsequent PCL aggregation.  
 
Figure 49. Reduction-triggered disassembly and dye release from PMOXA-graft(ss)-PCL 
nanoparticles studied by FCS. (A): Percentage of free dye measured by FCS curves: PMOXA-
graft(ss)-PCL 1 (grey triangles), PMOXA-graft(ss)-PCL 2 (white rectangles), PMOXA-graft(ss)-
PCL 3 (black diamonds), and PMOXA-b-PCL (black circles). Free dye only appeared for the 
PMOXA-graft(ss)-PCLs in presence of 10 mM DTT (upper curves), whereas incubation in PBS 
or PMOXA-b-PCL nanoparticles in 10 mM DTT did not show free dye up to 24 h (lower 
curves). (B): Normalized autocorrelation curves for PMOXA-graft(ss)-PCL 1 nanoparticles in 
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10 mM DTT: t = 0 min (circles), t = 24 min (crosses, 46% free dye), t = 24 h (diamonds, 100% 
free dye), t = 24 h no DTT (triangles).  
3.2.5. Loading properties of hydrophobic DOX inside nanoparticles formed by 
PMOXA-graft(ss)-PCLs 
DOX was used as hydrophobic model drug to be encapsulated into nanoparticles formed by 
PMOXA-graft(ss)-PCLs. All three PMOXA-graft(ss)-PCL nanoparticles were loaded with 
increasing amounts of DOX ranging from 50 to 250 µg with theoretical drug loading contents 
(DLC) of 4.8 wt%, 13 wt% and 20 wt%. The drug loading efficiencies (DLE) were around 40% 
for all the samples, which indicated that the theoretical drug loading contents and the 
difference of polymer chemical structures had very little influence on DLE (Table 5). The 
calculated 40% DLE was slightly lower than the DLE values (50%) reported recently for 
nanoparticles based on cross-linked polyurethane micelles (CCL-PUMs) and PCL-g-SS-PEG 
copolymers (Mn (1H NMR): 35.6 KDa - 66 KDa),8, 203 this could be explained by the non-
crosslinked molecule structure and lower Mn of our PMOXA-graft(ss)-PCLs. Our results 
demonstrated that the nanoparticles were loaded with more drugs when higher amounts of 
drug were added in the self-assembly solution. The final diameter and PDI of DOX loaded 
nanoparticles increased with increasing theoretical drug loading contents for all three 
PMOXA-graft(ss)-PCLs (Table 5 and Figure 50), which was caused by more encapsulated DOX 
occupied more 3D space in the nanoparticles. The diameter and PDI of DOX loaded 
nanoparticles changed from small to large with increasing theoretical DLC. This is similar to 
the results reported recently using PCL-g-SS-PEG ABPs.8 
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Table 5. DOX loading content (DLC), DOX loading efficiency (DLE), size and PDI of DOX loaded 
PMOXA-graft(SS)-PCL Nanoparticles.  
Polymer 
 
DLC (wt %)a 
 
DLE (%)b 
 
DLS 
in feed determined Size (nm) PDI 
PMOXA-graft(ss)-PCL 
1 
4.8 1.9±0.1 38.2±0.6 42±11 0.2 
13 5.8±0.2 40.8±1.6 48±12 0.3 
20 9.0±0.2 39.4±1.1 53±13 0.3 
      
PMOXA-graft(ss)-PCL 
2 
4.8 1.7±0.1 35.7±1.3 33 ±10 0.3 
13 5.9±0.1 41.5±0.7 38±10 0.3 
20 9.9±0.3 41.5±1.0 45±9 0.5 
PMOXA-graft(ss)-PCL 
3 
     
4.8 1.8±0.1 36.9±1.6 35±6 0.3 
13 5.9±0.1 41.1±0.9 32±7 0.4 
20 8.6±0.5 36±2.2 42±6 0.7 
a: DLC (wt%) = (weight of loaded drug/weight of polymer) * 100% 
b: DLE (%) = (weight of loaded drug/weight in feed) * 100% 
 
Figure 50. The changing trends of nanoparticle diameter and PDI (inset) with different 
increasing amount of DOX. (A): PMOXA-graft(ss)-PCL 1; (B): PMOXA-graft(ss)-PCL 2; (C): 
PMOXA-graft(ss)-PCL 3.  
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3.2.6. Intracellular DOX release and anti-proliferation activity of DOX-loaded 
PMOXA-graft(ss)-PCL nanoparticles. 
CLSM was used to investigate the cellular uptake and intracellular release behavior of DOX-
loaded PMOXA-graft(ss)-PCL nanoparticles in HeLa cells. DOX is known for its ability to 
intercalate with cellular DNA when released in cells causing an overlap of fluorescence 
signals of doxorubicin and the DNA-stain Hoechst.204, 205 Results demonstrated that after 1 h 
incubation of cells with DOX loaded PMOXA-graft(ss)-PCL 2 nanoparticles (0.25 µg/mL DOX), 
the fluorescence signal of DOX was colocalizing with the nucleus (Figure 51). This indicates 
the fast internalization of DOX-loaded nanoparticles and rapid release of DOX inside cells. 
The fast release was attributed to the disulfide bond cleavage in the presence of the 
reducing agent-GSH in concentrations of 0.5-10 mM in the intracellular compartment of 
cells.206 In addition, the fast increase of fluorescence intensity of DOX is in agreement with 
FCS data. The hydrophobic dye was released in several minutes under reducing conditions 
(Figure 49A). The fluorescence is determined only by the free DOX released from PMOXA-
graft(ss)-PCL nanoparticles. CLSM images clearly demonstrate that DOX has been released 
from PMOXA-graft(ss)-PCL nanoparticles into the cytosol and the released DOX is colocalized 
with the cell nucleus after 1 h (Figure 51A). In comparison, free DOX (0.25 µg/mL DOX) also 
accumulated in the cell nucleus after 1 h (Figure 51B). The CLSM images of DOX loaded 
nanoparticles formed by PMOXA-graft(ss)-PCL uptake behavior after 2, 4 and 8 h (Figure 52, 
53, 54) clearly demonstrated that the fluorescence intensity of DOX in the nucleus increased 
with incubation time. 
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Figure 51. CLSM images of intracellular DOX release from the reduction responsive DOX 
loaded PMOXA-graft(ss)-PCL 2 nanoparticles in HeLa cells after 1 h. For each panel, images 
from left to right show cell nuclei stained by Hoechst 33342 (blue), DOX fluorescence in cells 
(red), and overlays of the two images. A: DOX loaded PMOXA-graft(ss)-PCL 2 nanoparticles 
(0.25 µg/mL DOX); (B) free DOX as control (0.25 µg/mL DOX).  
 
 
Figure 52. CLSM images of intracellular DOX release from the reduction responsive DOX 
loaded PMOXA-graft(ss)-PCL 2 nanoparticles in HeLa cells after 2 h incubation. For each 
panel, images from left to right show cell nuclei stained by Hoechst 33342 (blue), DOX 
fluorescence in cells (red) and overlays of the two images. A: DOX loaded PMOXA-graft(ss)-
PCL 2 nanoparticles (0.25 µg/mL DOX); (B) free DOX as control (0.25 µg/mL DOX).  
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Figure 53. CLSM images of intracellular DOX release from the reduction responsive DOX 
loaded PMOXA-graft(ss)-PCL 2 nanoparticles in HeLa cells after 4 h incubation. For each 
panel, images from left to right show cell nuclei stained by Hoechst 33342 (blue), DOX 
fluorescence in cells (red) and overlays of the two images. A: DOX loaded PMOXA-graft(ss)-
PCL 2 nanoparticles (0.25 µg/mL DOX); (B) free DOX as control (0.25 µg/mL DOX).  
 
 
Figure 54. CLSM images of intracellular DOX release from the reduction responsive DOX 
loaded PMOXA-graft(ss)-PCL 2 nanoparticles in HeLa cells after 8 h incubation. For each 
panel, images from left to right show cell nuclei stained by Hoechst 33342 (blue), DOX 
fluorescence in cells (red) and overlays of the two images. A: DOX loaded PMOXA-graft(ss)-
PCL 2 nanoparticles (0.25 µg/mL DOX); (B) free DOX as control (0.25 µg/mL DOX).  
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The three PMOXA-graft(ss)-PCL copolymers did not show toxicity to HeLa cells when 
measured by MTS. The cell viability remained high than 90% for copolymer concentrations 
ranging from 0.1 to 1 mg/mL after 48 h incubation (Figure 55). The good biocompatibility of 
this new copolymer indicates it as a promising candidate for drug delivery applications.  
DOX-loaded PMOXA-graft(ss)-PCL nanoparticles exhibit a higher anti-proliferation effect in 
HeLa cells than DOX-loaded PMOXA-b-PCL after 48 h (DOX concentration ranging from 0.9, 
2.7, 4.5 to 9 µg/mL) (Figure 56). Surprisingly, the cell viability of the lowest concentration 
(0.9 µg/mL) and highest concentration (9 µg/mL) of DOX loaded PMOXA-graft(ss)-PCL 
nanoparticles compared with DOX loaded PMOXA-b-PCL was not as higher than for 
concentrations of 2.7 µg/mL and 4.5 µg/mL, which indicated that the drug concentration 
also plays an essential role in increasing the anti-proliferation efficiency. For DOX 
concentrations of 4.5 µg/mL, the efficiency of anti-proliferation for HeLa cells for DOX-
loaded PMOXA-graft(SS)-PCL was improved at least 40% comparing with DOX-loaded 
PMOXA-b-PCL nanoparticles. It should be noticed that the highest concentration of 
copolymer in the anti-proliferation effect for HeLa cells was 0.07 mg/mL, which is much 
lower than the one tested for cytotoxicity, respectively 1 mg/mL. As a result, the decreased 
viability of HeLa cells was caused by released DOX rather than the copolymer itself.  
 
Figure 55. Viabilities of HeLa cells after 48 h incubation of PMOXA-graft(SS)-PCL 
nanoparticles. All the data are presented as the average ± standard deviation (n = 4).  
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Figure 56. Viability of HeLa cells after 48 h incubation with DOX loaded PMOXA-graft(SS)-PCL 
nanoparticles, DOX loaded PMOXA-b-PCL nanoparticles and free DOX. DOX dosage was 0.9 
µg/mL, 2.7 µg/mL, 4.5 µg/mL and 9 µg/mL. All the data are presented as the average ± 
standard deviation (n = 8).  
3.3. Conclusion 
A novel reduction responsive PMOXA-graft(ss)-PCL ABPs were synthesized through the thiol-
disulfide exchange reaction between thiolated PMOXA (PMOXA-SH) and pyridyl disulfide 
functionalized poly(ε-caprolactone) (PCL-co-PPCL). This new type of biocompatible 
copolymer is not toxic itself, biocompatible, and biodegradable ABPs. Its self-assembled 
nanoparticle can encapsulate hydrophobic molecules, such as DOX, during the self-assembly 
process in aqueous solution with around 40% loading efficiency. In a suitable reducing 
condition, PMOXA-graft(ss)-PCL nanoparticles can release their encapsulated cargoes faster 
than PMOXA-b-PCL self-assemblies which show no reduction responsiveness. Our new 
reduction responsive PMOXA-graft(ss)-PCL is a promising candidate for targeted drug 
delivery in tumor cells that contain a much higher amount of reducing agents than the 
normal cells. 
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4. Design and synthesis of gene delivery nanocarriers based 
on reduction responsive amphiphilic poly(2-ethyl-2-
oxazoline)-block-poly(ε-caprolactone)-ss-poly(L-lysine) 
(PEtOXA-b-PCL-ss-PLL) copolymers 
Dalin Wu, Jason Duskey, Cornelia Palivan, Wolfgang Meier* 
Some of the result about the polymer synthesis is being organized and wrote as the 
manuscript.   
4.1. Introduction 
Nucleic acids, including plasmid DNA, antisense oligodeoxyribonucleotides (ODN), and small 
interfering RNA (siRNA) have been receiving more and more attention as novel genetic drugs 
for treatment of single gene disorders, cancers, DNA vaccines, and regenerative medicine.207 
However, because nucleic acids are susceptible to hydrolytic and enzymatic degradation in 
the body and cannot pass through the cytoplasmic membrane, a safe and efficient delivery 
nanocarrier is necessary to deliver nucleic acids to maximally exert their therapeutic 
potential in vivo. Natural viruses are highly efficient delivery vehicles for nucleic acids, due to 
their ability to complex with nucleic acids through charge interaction to form polyplexes. 
This strategy enhances the stability of nucleic acids against hydrolytic and enzymatic 
degradation in the body. 76, 208, 209 However, non-viral delivery of nucleic acids involves two 
key stages: extracellular delivery and intracellular delivery100 (Figure 57). Each step of 
delivery requires specific qualities of the nanocarriers. During the process of extracellular 
delivery, the first obstacle is to overcome the presence of nucleases which attack foreign 
nucleotides rapidly. In addition, biomacromolecules, such as serum proteins, can non-
specifically interact with polyplexes inducing their dissociation or aggregation. Because of 
this, high stability and high resistance to protein absorption must be prerequisites for 
designing systemically injectable polyplexes. Even though stealth complexes can be obtained, 
the polyplexes should be less than 200 nm in order to take advantage of the EPR1 effect to 
increase accumulation into tumor cells. Once delivered, nanocarriers are entrapped by the 
endosomes (pH 6.2-6.8) which is significantly lower than the extracellular matrix with a pH of 
7.4. In order to ensure intracellular delivery to the nucleus the polyplex should escape the 
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endosome before it becomes a lysosome (pH of 4-5). Finally, the polyplexes DNA cargo must 
overcome the nuclear membrane to be functional. This requires the polyplexes to have the 
following properties : i) high stability during circulation in blood, ii) high resistance to 
biomolecules absorption, iii) size bellow 200 nm to utilize EPR1 effect, iv) adsorption by the 
cellular membrane, for extracellular delivery, v) fast endosomal escape, vi) gene release 
from the polyplex, vii) nuclear internalization, and viii) minimal cytotoxicity of polycations, 
for intracellular delivery.100  
 
Figure 57. Schematic illustration of gene delivery from injection to cell nucleus and 
prerequisites for polyplexes to be successful non-viral vectors.100  
 
In order to address the above mentioned requirements, we designed and synthesized a new 
type of amphiphilic triblock ABC copolymer poly(2-ethyl-2-oxazoline)-block-poly(ε-
caprolactone)-ss-poly(L-lysine) (PEtOXA-b-PCL-ss-PLL) through the ring-opening 
polymerization of 2-ethyll-2-oxazoline, ε-caprolactone and ε-benzyloxycarbonyl-L-lysine N-
carboxyanhydride. Because of its amphiphilicity, PEtOXA-b-PCL-ss-PLL can self-assemble into 
micelles in aqueous solution (Figure 58). It should be emphasized that hydrophilic PEtOXA 
was used instead of the hydrophilic PMOXA which was used in the section 3 was that 
PMOXA was not soluble in toluene during the initiation of ε-carprolactone in presence of 
catalyst stannous octoate. Stannous octoate can only express catalytic effect in the solution 
with low polarity, like toluene. However, PEtOXA, due to a more methylene group in 
repeating unit, it can be soluble in toluene and initiate the polymerization of ε-carprolactone.    
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Figure 58. Schematic representation of the self-assembly of PEtOXA-b-PCL-ss-PLL in micelles 
in aqueous solution. 
 
This specific copolymer structure was chosen because PEtOXA, as the hydrophilic block, can 
stretch over the surface of micelles endowing the micelles with “stealth behavior” and 
enabling prolonged circulation time in the blood. PCL block is a biocompatible and 
biodegradable hydrophobic polymer block can stabilize the nanostructures after 
complexation with DNA. Finally, PLL as the hydrophilic polymer block with pKa e of 9.85 ± 
0.2210 can bind with genes through the positive and negative interactions in physiological 
condition. The process of PEtOXA-b-PCL-ss-PLL micelles complex with gene to form the 
polyplex is illustrated in Figure 59.  
 
Figure 59. Schematic representation of process of polyplex formed by gene and PEtOXA-b-
PCL-ss-PLL micelles. 
 
In the structure of PEtOXA-b-PCL-ss-PLL, the disulfide bond that connects the PEtOXA-b-PCL 
and hydrophilic PLL can be reduced in the same way as GSH inside of the cancer cells. By 
reducing the disulfide bond of the polyplexes, the structures will fall apart releasing the DNA. 
This process could enhance the escape of DNA from the endosomes (Figure 60).  
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Figure 60. Schematic representation for the GSH triggered separation of gene and PEtOXA-b-
PCL-ss-PLL micelle polyplexes.  
 
 As controls, two block copolymers, poly(2-ethyl-2-oxazoline)-ss-poly(L-lysine) (PEtOXA-ss-
PLL) and poly(2-ethyl-2-oxazoline)-block-poly(L-lysine) (PEtOXA-b-PLL), were also synthesized. 
Neither of them have a PCL hydrophobic block. Also these, polymers contain only PEtOXA 
and polylysine blocks connected by reduction responsive disulfide and non-reduction 
sensitive carbon-carbon bond, responsively. Therefore, the overall influence of various 
blocks and reducing potential of the disulfide bond can be carefully investigated for DNA 
delivery.  
4.2. Results and discussion 
4.2.1. Synthesis and characterization of PEtOXA-b-PCL-ss-PLL, PEtOXA-ss-PLL and 
PEtOXA-b-PLL 
4.2.1.1. Detailed PEtOXA-b-PCL-ss-PLL, PEtOXA-ss-PLL and PEtOXA-b-PLL 
synthesis procedure  
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Scheme 10. Synthesis route of PEtOXA-b-PCL-ss-PLL.a 
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a: Reagents and conditions: (i) 2-Mercaptoethanol, acetic acid, MeOH, RT for 2 h under 
argon; (ii) N-(tert-butoxycarbonyl)-2-aminoethanethiol, MeOH/DCM, RT for 20 h under 
argon; (iii) methyl trifluoromethanesulfonate, acetonitrile, 80 °C for 24 h under argon: (iv) ε-
caprolactone, Tin(II) 2-ethylhexanoate, toluene, 110 °C for 24 h under argon; (v) succinic 
anhydride, triethylamine, DMAP, chloroform, RT for 72 h under argon; (vi) 2-Boc-aminoethyl 
2'-hydroxyethyl disulfide, DCC, DMAP, chloroform, RT for 72 h under argon; (vii) TFA, 0 °C for 
1 h; (viii) ε-benzyloxycarbonyl-L-lysine N-carboxyanhydride, DIPEA, DMF, RT for 72 h under 
argon; (ix) TFA, HBr in acetic acid solution (33%), 0 °C for 1.5h. 
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Scheme 11. Synthesis route of PEtOXA-ss-PLL and PEtOXA-b-PLL.b 
b: Reagents and conditions: (i) Methyl trifluoromethanesulfonate, acetonitrile, 80 °C for 24 h 
under argon; (ii) potassium thioacetate, RT for 24 h under argon; (iii) diphenyl disulfide, 
PEtOXA-SAc, NH3/MeOH (7N), RT for 48 h under argon; (iv) PEtOXA-ss-Ph, cysteamine, 
MeOH, RT for 48 h under argon; (v) PEtOXA-ss-NH2, ε-benzyloxycarbonyl-L-lysine N-
carboxyanhydride, DMF, RT for 72 h under argon; (vi) PEtOXA-ss-PzLL, TFA, HBr in acetic acid 
(33%), 0 °C for 1.5 h; (vii) methyl trifluoromethanesulfonate, acetonitrile, 80 °C for 24 h 
under argon; (viii) NH3/MeOH (7N), RT for 24 h under argon; (ix) PEtOXA-NH2, ε-
benzyloxycarbonyl-L-lysine N-carboxyanhydride, DMF, RT for 72 h under argon; (x) PEtOXA-
b-PzLL, TFA, HBr in acetic acid solution (33%), 0 °C for 1.5 h.  
  
4.2.1.2. Discussion about the synthesis procedure and result 
Synthesis of tert-butyl N-(2[(2-hydroxyethyl)disulfanyl]ethyl)carbamate. Thiol-disulfide 
exchange reaction between diphenyl disulfide and 2-mercaptoethanol was used to 
synthesize 2-(2-(pyridin-2-yl)disulfanyl)ethanol. The same reaction type was further used to 
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synthesize 2-Boc-aminoethyl 2'-hydroxyethyl disulfide from 2-(2-(pyridin-2-
yl)disulfanyl)ethanol and N-(tert-butoxycarbonyl)-2-aminoethanethiol at RT. The 1H NMR 
and 13C NMR proved the efficiency and the high purity of 2-(2-(pyridin-2-yl)disulfanyl)ethanol 
and N-(tert-butoxycarbonyl)-2-aminoethanethiol synthesis after the purification by column 
chromatography (Figure 61, Figure 62 and Figure 63). 
 
Figure 61. 1H NMR spectrum of 2-(2-(pyridin-2-yl)disulfanyl)ethanol in CDCl3. 
 
Figure 62. 1H NMR spectrum of 2-Boc-aminoethyl 2'-hydroxyethyl disulfide in CDCl3. 
 
 
Figure 63. 13C NMR spectrum of 2-Boc-aminoethyl 2'-hydroxyethyl disulfide in CDCl3. 
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Synthesis of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone)-OH (PEtOXA-b-PCL-OH). 
PEtOXA-OH was synthesized by the ROP of 2-ethyl-2-oxazoline initiated by methyl 
trifluoromethanesulfonate in acetonitrile. The 1H NMR spectrum (Figure 64) proved the 
efficiency of the reaction and PDI values of 1.15 from the GPC measurements (Figure 65) 
underlines the living cationic ROP property of 2-ethyl-2-oxazoline. 
 
Figure 64. 1H NMR spectrum of PEtOXA-OH in CDCl3. 
 
 
Figure 65. GPC curves of PEtOXA-OH, PEtOXA-b-PCL-ss-NH2, PEtOXA-b-PCL-ss-PzLL1 and 
PEtOXA-b-PCL-ss-PzLL2. 
 
Lyophilized PEtOXA-OH was first mixed with ε-caprolactone. Then, hot freshly distilled 
toluene was added to dissolve the PEtOXA-OH, because otherwise it cannot be dissolved. 
After the ROP of ε-caprolactone, the product was purified by precipitation in diethyl ether 
easily. The peaks at 1.10 ppm (characteristic for the protons on methyl groups of PEtOXA-OH) 
and 4.06 ppm (characteristic for the protons of methylene groups next to oxygen on PCL) 
from 1H NMR spectrum proved the presence of PEtOXA-OH and PCL. The mono peak in the 
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GPC plot proved the covalent bonding between PEtOXA and PCL (Figure 66). The PDI of 
PEtOXA-b-PCL-OH was 1.20 indicating the living ROP of ε-caprolactone. In addition, in the 
GPC curve, there is no additional shoulder proving complete polymerization of PEtOXA-OH 
(Figure 65). 
 
Figure 66. The 1H NMR spectrum of PEtOXA-b-PCL-OH in CDCl3. 
 
Synthesis of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone)-ss-NH2.TFA (PEtOXA-b-
PCL-ss-NH2.TFA). PEtOXA-b-PCL-OH was first reacted with succinic anhydride to synthesize 
carboxyl acid PEtOXA-b-PCL-COOH. The appearance of a new peak at 2.63 ppm characteristic 
for the protons on methylene next to carboxylic group in figure 67 demonstrated the 
successful carboxylation of PEtOXA-b-PCL. Further, PEtOXA-b-PCL-COOH was reacted with 
tert-butyl N-(2[(2-hydroxyethyl)disulfanyl]ethyl)carbamate in presence of DCC and DMAP. 
The appearance of new peaks at 1.44 ppm protons on Boc and 2.91 ppm, (protons on the 
methylene groups next to disulfide) in figure 68 shows the coupling of tert-butyl N-(2[(2-
hydroxyethyl)disulfanyl]ethyl)carbamate on the PEtOXA-b-PCL. Finally, PEtOXA-b-PCL-NH2-
TFA macroinitiator was synthesized by deprotecting Boc in the presence of TFA. The 
disappearance of the peak at 1.44 ppm, characteristic for protons on the Boc protecting 
group in figure 69 demonstrated the complete deprotection of Boc.  
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Figure 67. 1H NMR spectrum of PEtOXA-b-PCL-COOH in CDCl3. 
 
Figure 68. 1H NMR spectrum of PEtOXA-b-PCL-ss-NHBoc in CDCl3. 
 
Figure 69. 1H NMR spectrum of PEtOXA-b-PCL-ss-NH2.TFA in CDCl3 
 
Synthesis of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone)-ss-poly(L-lysine) 
(PEtOXA-b-PCL-ss-PLL). PEtOXA-b-PCL-ss-NH2.TFA initiated the ROP of ε-benzyloxycarbonyl-
L-lysine N-carboxyanhydride in DMF with DIPEA. For that, DIPEA was added to neutralize the 
TFA and increase the reactivity of the primary amines. The new peaks at 7.26 ppm, 
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characteristic for the hydrogens on phenyl ring, and 4.99 ppm, for the protons on methylene 
next to phenyl ring, demonstrated the successful polymerization of poly(ε-
benzyloxycarbonyl-L-lysine) (Figure 70). The GPC plot (Figure 65) shows only one narrow 
distributed retention peak, proving the successful coupling of poly(ε-benzyloxycarbonyl-L-
lysine) and PEtOXA-b-PCL diblock copolymer. From the GPC (Figure 65), the Mns of the two 
PEtOXA-b-PCL-ss-PzLLs were determined as 21.2 KDa and 24.8 KDa. Importantly, the PDIs of 
two PEtOXA-b-PCL-ss-PzLLs were 1.17 and 1.21, which demonstrates the living ROP of ε-
benzyloxycarbonyl-L-lysine N-carboxyanhydride. PEtOXA-b-PCL-ss-PLL was synthesized by 
reacting PEtOXA-b-PCL-ss-PzLL with TFA and HBr in acetic acid solution (33%). The 
disappearance of the peaks at 7.26 ppm, (corresponding to hydrogens on phenyl ring, and 
4.99 ppm, characteristic for protons on methylene next to phenyl ring, demonstrated the 
successful deprotection of phenyl rings on PzLL (Figure 71).  
 
Figure 70. 1H NMR spectrum of PEtOXA-b-PCL-ss-PzLL in CDCl3. 
 
 
Figure 71. 1H NMR spectrum of PEtOXA-b-PCL-ss-PzLL in d6-DMSO. 
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Synthesis of Poly(2-ethyl-2-oxazoline) disulfide amine (PEtOXA-ss-NH2). The synthesis 
method of PEtOXA-SAc and PEtOXA-ss-Py was performed according to the previously 
published procedure. 1H NMR spectra (Figure72) demonstrated the successful synthesis with 
high degree of purity. Further the thiol-disulfide exchanging reaction between PEtOXA-ss-Py 
and cysteamine was applied to synthesize PEtOXA-ss-NH2. The disappearance of the peaks at 
7.0 ppm and 8.5 ppm corresponding to the protons on the pyridine of PEtOXA-ss-Py and 
appearance of a new peak at 4.15 ppm, assigned to the protons on methylene next to amine 
of PEtOXA-ss-NH2 in 1H NMR spectra (Figure 73), suggests the successful synthesis of 
PEtOXA-ss-NH2. In addition, the color of reaction mixture changed from colorless to yellow 
due to the appearance of a byproduct, pyridine-2-thione, that also proved the success of the 
thiol-disulfide exchanging reaction. The PDI of PEtOXA-ss-NH2 is 1.22 (Figure 74). 
 
Figure 72. 1H NMR spectrum of PEtOXA-ss-Py in CDCl3. 
 
Figure 73. 1H NMR spectrum of PEtOXA-ss-NH2 in CDCl3. 
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Figure 74. GPC curves of PEtOXA-ss-NH2 and PEtOXA-ss-PzLL in DMF. 
 
Synthesis of Poly(2-ethyl-2-oxazoline)-ss-poly(L-lysine) (PEtOXA-ss-PLL). PEtOXA-ss-PzLL 
was synthesized through the ROP of ε-benzyloxycarbonyl-L-lysine N-carboxyanhydride 
initiated by the macroinitiator PEtOXA-ss-NH2 in a DMF solution. In the 1H NMR spectrum, 
the new peaks at 7.26 ppm, characteristic for the protons from the phenyl ring, and 4.99 
ppm (Figure 75), assigned to the protons on methylene groups next to phenyl ring, 
demonstrated the synthesis of poly(ε-benzyloxycarbonyl-L-lysine). One single retention peak 
in the GPC indicated the successful coupling reaction (Figure 74). PEtOXA-ss-PzLL had a low 
PDI around 1.30 and a molecular weight of 25.6 KDa.  
The deprotection of ε-benzyloxycarbonyl was carried out in a mixture of TFA and HBr in 
acetic acid solution (33%) at 0 °C. The disappearance of signals at 7.26 ppm and 4.99 ppm in 
1H NMR spectrum demonstrated the successful deprotection of ε-benzyloxycarbonyl groups 
from PzLL (Figure 76).  
 
Figure 75. 1H NMR spectrum of PEtOXA-ss-NH2 in CDCl3. 
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Figure 76. 1H NMR spectrum of PEtOXA-ss-NH2 in D2O. 
 
Synthesis of primary Amine Ended Poly(2-ethyl-2-oxazoline) (PEtOXA-NH2). The synthesis 
of PEtOXA-NH2 was performed according to the method previously published. The 1H NMR 
spectrum (Figure 77) demonstrated the successful synthesis of PEtOXA-NH2 with high purity. 
The polymer has a Mn of 6.7 KDa and a PDI of 1.30 (Figure 78). 
 
 
Figure 77. 1H NMR spectrum of PEtOXA-NH2 in CDCl3. 
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Figure 78. GPC curves of PEtOXA-NH2 and PEtOXA-b-PzLL in DMF. 
 
Synthesis of Poly(2-ethyl-2-oxazoline)-block-Poly(L-lysine) (PEtOXA-b-PLL). PEtOXA-b-PzLL 
was synthesized through the ROP of ε-benzyloxycarbonyl-L-lysine N-carboxyanhydride 
initiated by macroinitiator PEtOXA-NH2 in a DMF solution. In the 1H NMR spectrum, the new 
peaks at 7.23 ppm, characteristic for the protons of phenyl ring, and 4.99 ppm, assigned to 
the protons of the methylene groups next to phenyl ring, demonstrated the formation of of 
poly(ε-benzyloxycarbonyl-L-lysine) (Figure 79). A GPC plot shows only one retention peak 
corresponding to PEtOXA-b-PzLL shifted to the right side compared with the macroinitiator 
PEtOXA-NH2 due to the increase of the Mn by polymerization (Figure 78). PEtOXA-b-PzLL has 
a PDI of 1.71 and a Mn of 21.7 KDa.  
The deprotection of ε-benzyloxycarbonyl was carried out in a mixture of TFA and HBr in 
acetic acid solution (33%) at 0 °C. The disappearance of the peaks at 7.26 ppm, characteristic 
for the protons from the phenyl ring, and 4.99 ppm, assigned to the protons from (the 
methylene group near the phenyl ring), demonstrated the successful deprotection of ε-
benzyloxycarbonyl groups from PzLL (Figure 80). 
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Figure 79. 1H NMR spectrum of PEtOXA-b-PzLL in CDCl3. 
 
 
Figure 80. 1H NMR spectrum of PEtOXA-b-PLL in D2O. 
 
4.2.2. Preparation and characterization of self-assemblies of PEtOXA-ss-PzLL and 
PEtOXA-b-PCL-ss-PLL 
4.2.2.1. Reduction responsive property of PEtOXA-ss-PzLL. 
GPC was used to characterize the reduction responsive property of PEtOXA60-ss-PzLL58. The 
PEtOXA60-ss-PzLL58 (5 mg) was dissolved in the DMF solution (1.2 mL) containing 10 mM DTT. 
After 2 h treatment, the sample was measured by GPC. Compared with PEtOXA60-ss-PzLL58 
with or without DTT that shows one retention peak is seen until reduction occurs leading to 
two retention peaks corresponding to the lower Mn polymer fragments (Figure 81). 
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Figure 81. GPC curves of PEtOXA60-ss-PzLL58 and PEtOXA60-ss-PzLL58 treated with 10 mM DTT 
in DMF. 
 
4.2.2.2. Reduction responsive property of PEtOXA-ss-PzLL self-assemblies. 
Due the hydrophobic property of the phenyl ring group on the repeating unit of lysine, 
PEtOXA-ss-PzLL is amphiphilic. This means that PEtOXA-ss-PzLL can self-assemble in aqueous 
solution into nanostructures containing PzLL as the hydrophobic domain and PEtOXA as the 
hydrophilic block. The CMC values of PEtOXA60-ss-PzLL39 and PEtOXA60-ss-PzLL58 are 3.5*10-3 
mg/mL and 0.4*10 - 3 mg/mL (Figure 82). In addition, according to the TEM images and DLS 
results, the self-assembled nanostructures of both PEtOXA60-ss-PzLL39 and PEtOXA60-ss-
PzLL58 are with diameters of 58 ± 22 nm and 71 ± 20 nm (Figure 83). Because the 
hydrophobic block and hydrophilic block are connected by a disulfide bond, the self-
assembled nanostructures will disassemble in the presence of the reduction agent, DTT. By 
treating the solution containing of PEtOXA60-ss-PzLL39 and PEtOXA60-ss-PzLL58 self-assembles 
with 10 mM DTT, the diameter of self-assembled nanostructures changed from 160 nm to 
650 nm in 2 h, and to 1000 nm in 6 h (Figure 84). Finally, after 24 h, only hydrophobic 
polymer aggregates were present (Figure 85C).  
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Figure 82. The fluorescence intensity ratio I383/I372 of pyrene as a function of PEtOXA60-ss-
PzLLy copolymer concentration. The intersections are the values of CMC. A. PEtOXA60-ss-
PzLL39; B. PEtOXA60-ss-PzLL58.  
 
 
Figure 83. TEM images of self-assemblies of PEtOXA-ss-PzLL. (A). PEtOXA60-ss-PzLL39; (B). 
PEtOXA60-ss-PzLL58 (C). DLS results of self-assemblies of PEtOXA60-ss-PzLL39 and PEtOXA60-ss-
PzLL58.  
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Figure 84. The self-assembled nanostructures size change after DTT was added with finial 
DTT concentration 10 mM. 
 
 
Figure 85. Digital images of nanoparticles treated with DTT with final concentration 10 mM. 
(A). 2 h after the addition of DTT; (B). 6 h after the addition of DTT; (C). 24 h after the 
addition of DTT.  
 
4.2.2.3. Reduction responsive property of PEtOXA-b-PCL-ss-PzLL. 
GPC was used to characterize the reduction responsive property PEtOXA98-b-PCL100-ss-PzLL83. 
PEtOXA98-b-PCL100-ss-PzLL83 (3 mg) was dissolved in a DMF solution (1.0 mL) containing 10 
mM DTT. After 6 h, the sample was measured by GPC. PEtOXA98-b-PCL100-ss-PzLL83 without 
being treated with DTT showed only one retention peak, while the polymer treated with DTT 
showed a retention peak corresponding to lower Mn than the polymer itself were indicating 
the PEtOXA98-b-PCL100 (Mn = 21.1 KDa) and PzLL83 (Mn = 25.4 KDa) blocks (Figure 86) cleaved 
in the presence of DTT.  
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Figure 86. GPC curves of PEtOXA98-b-PCL100-ss-PzLL83 treated with 10 mM DTT in DMF. 
 
4.2.2.4. Reduction responsive property of PEtOXA-b-PCL-ss-PzLL self-assemblies. 
Due to the amphiphilicity of PEtOXA-b-PCL-ss-PLLs, they can self-assemble in aqueous 
solution. TEM and DLS measurements demonstrated that PEtOXA-b-PCL-ss-PLL can self-
assemble into nanostructures with diameter around 31 nm (Figure 87) by co-solvent method. 
 
Figure 87. TEM images of self-assemblies of PEtOXA-ss-PzLL. (A). PEtOXA98-b-PCL100-ss-PLL83; 
(B). PEtOXA98-b-PCL100-ss-PLL41; (C). DLS results of self-assemblies of PEtOXA98-b-PCL100-ss-
PLL83 and PEtOXA98-b-PCL100-ss-PLL83. 
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Figure 88. 1H NMR spectrum of PEtOXA-PCL-ss-PLL in D2O. 
 
The clear proton singles corresponding to PEtOXA in D2O demonstrate the PEtOXA is water 
soluble and surround over the hydrophobic PCL core (Figure 88). In addition, the zeta 
potential measurement showed the zeta potential values are 26 ± 1.4 mV and 13 ± 1.5 mV 
for PEtOXA98-b-PCL100-ss-PLL83 and PEtOXA98-b-PCL100-ss-PLL41, respectively (Table 6), proving 
the presence of positively charged PLL (Pka = 9.85 ± 0.20) on the outside surface of self-
assembled nanostructures (Figure 89).210  
 
The results of NMR, TEM, DLS, and zeta potential proved the self-assembled nanostructures 
were micelles with hydrophobic PCL as the core surrounded by the hydrophilic PEtOXA and 
PLL(Figure 89). In the presence of DTT the disulfide bond from PEtOXA98-b-PCL100-ss-PLL41 will 
be reduced and two new polymer blocks will be obtained; one corresponding to the 
amphiphilic block copolymer PEtOXA98-b-PCL100, and another to homo PLL41. Due to the 
amphiphilic property of PEtOXA98-b-PCL100, the polymer block can re-self-assemble after DTT 
treatment. As expected, treating 2 mg/mL PEtOXA98-b-PCL100-ss-PLL41 self-assembled 
micelles solution with 10 mM DTT resulted in no change of the self-assembled diameter 
(Figure 90).  
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Figure 89. The representation of the PEtOXA-b-PCL-ss-PLL formed micelles structure. 
 
 
Figure 90. The micelles size change of PEtOXA98-b-PCL100-ss-PLL83 after treated by 10 mM 
DTT solution. 
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Table 6. The chemical parameter results of PEtOXA-ss-PzLL and PEtOXA-b-PCL-ss-PLL from 
the measurements of 1H NMR, GPC, and self-assembly results from the measurements of 
DLS and zeta-potential.  
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4.2.3. The binding of plasmid DNA with PEtOXA-b-PCL-ss-PLL self-assembled 
micelles  
Due to the presence of the positive charges on the surface of the self-assembled micelles, 
PEtOXA-b-PCL-ss-PLLs can form a complex with negative DNA in aqueous solution. The 
results of an electrophoresis band shift assay with the ratio of N/P of 7 between PEtOXA-b-
PCL-ss-PLLs and DNA proved the DNA can bind with micelles (Figure 91). The free DNA 
migrated through the gel, however, in presence of the micelles of PEtOXA-b-PCL-ss-PLL, the 
DNA remained in the well indicating binding to the micelles. 
 
Figure 91. The electrophoresis results of free DNA and PEtOXA-b-PCL-ss-PLL micelles and 
DNA complexation.  
 
4.3. Conclusions 
Reduction responsive PEtOXA-b-PCL-ss-PLL triblock copolymers have been successfully 
synthesized through the ring opening polymerization of 2-ethyl-2-oxazoline, ε-caprolactone, 
and ε-benzyloxycarbonyl-L-lysine N-carboxyanhydride. The results of TEM, DLS, and zeta 
potential demonstrated that PEtOXA-b-PCL-ss-PLL triblock copolymers can self-assembled 
into micelles with diameter around 30 nm in aqueous solution with the hydrophobic PCL 
forming the core and hydrophilic PEtOXA and PLL forming the corona of the micelles. The 
reduction experiments showed that PEtOXA-b-PCL-ss-PLL triblock copolymers exhibit 
reduction responsiveness in the presence of a reducing agent (DTT). Finally, the self-
assembled micelles complex negatively charged DNA in a pH 7.4 aqueous solution.  
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5. General conclusions and outlook 
In this work, the synthesis, self-assembly, and application of three types of ABPs were 
presented. The main conclusions are: 
 A library of PDMS-b-PMOXA was synthesized. The influence of various parameters, 
including initial concentration, self-assembly method, buffer, and molecular weight 
of each block on self-assembly nanostructures has been investigated in details. The 
3D phase diagram has been prepared based on the self-assembly nanostructures and 
molecular weight of PDMS and fPMOXA. In the copolymer system PDMS65-b-PMOXA10-
38, we found the same diameter changing trend of self-assembled nanostructures 
with PBD-b-PEG system reported by S Förster et al.147, 211 In addition, we found a 
“new” self-assembled nanostructure with similar size of polymersome (80 nm-100 
nm) with “non-hollow” cavity. Due the resolution limitation of Cyro-TEM and SAXS, 
the clear inner structure is still unknown.  For PDMS39-b-PMOXA6-22 and PDMS16-b-
PMOXA2-10, surprisingly, we did not found the self-assembled polymersome. In 
addition, the Mn of copolymer are still lower than 10 KDa, stickily speaking, they are 
oligomers, so it is quite difficult to predict the changing trend in the case of 
copolymers with high Mn.  
 The grafted shaped ABPs PMOXA-graft(ss)-PCL was synthesized by combining the 
cationic polymerization, coordination insertion polymerization, and thiol-disulfide 
exchange reaction methods. The synthesized PMOXA-graft(ss)-PCLs and their 
corresponding self-assembly nanoparticles show reduction responsiveness as proved 
by 1H NMR, TEM, DLS, and FCS. In addition, the loaded molecules in the self-
assembled nanoparticles can be released in the presence of reducing agents. Cell 
culture experiments showed that introduction of the disulfide group into the ABPs 
enhance the overall performance as smart nanocarriers in the drug delivery. 
 The reduction responsive triblock ABPs PEtOXA-b-PCL-ss-PLLs were synthesized 
through cationic polymerization, coordination insertion polymerization, and ROP 
polymerization methods. The 1H NMR and GPC results demonstrated right chemical 
structure. The DLS, TEM, and zeta-potential results showed that these ABPs can self-
assemble into micelles in aqueous solutions with PCL forming the core and 
hydrophilic PLL and PEtOXA as the shell. The primary electrophoresis result 
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demonstrated that negatively charged DNA can bind on self-assembled micelles, 
which indicated that this reduction responsive triblock ABPs PEtOXA-b-PCL-ss-PLLs 
can be promising candidates for gene delivery. However, this system still cannot 
mimic the virus perfectly. The main reason that virus is a high efficacy gene carrier is 
that after it is uptake by cells, in the lower pH endosome, a protein segment will 
change from hydrophilic to hydrophobic, which can help the gene escape from 
endosome in a very short time.100 For our PEtOXA-PCL-ss-PLL system, even though 
the PLL separates from the copolymer, the hydrophobic PCL still cannot be exposed 
outside and function as disturber in the endosome. Because PEtOXA-PCL still keeps 
the amphiphilic property. This process cannot accelerate the escape of gene from 
endosome; only accelerate the separation of gene from the copolymer complex.  
 
Basing on the above results, the following directions are suggested to be further investigated: 
 Use PDMS with PDIs 1.5-2.0, rather than 1.0-1.1, to synthesize the ABPs PDMS-b-
PMOXA and investigate the influence of PDIs of PDMS on the self-assembled 
structures. It is because the fact that increasing the PDI of hydrophobic block can 
really influence the final self-assembly nanostructures in bulk and in solution.212, 213 
For example, Adi Eisenberg et al investigated the ABP system polystyrene-block-
poly(acrylic acid) (PS-b-PAA), they found the diameters of self-assembled 
nanostructures decreased from 365±230 nm to 85±15 nm (apparent mass fraction of 
vesicles from 100% to 63%) with increasing the PDI of PAA from 1.37 to 2.13.53      
 For the ABPs PEtOXA-b-PCL-ss-PLLs, a more detailed investigation of micelles as gene 
delivery carriers should be done, including cytotoxicity measurements of the 
polymers, characterization of nanostructures of PEtOXA-b-PCL-ss-PLLs after 
complexation with genes by TEM, DLS, and zeta potential, and the overall evaluation 
of the performance of PEtOXA-b-PCL-ss-PLLs as gene delivery nanocarrier.  
 Basing on the PEtOXA-b-PCL-ss-PLLs platform, it may be interesting to synthesize dual 
responsive triblock ABPs, for example adding a pH responsive linker between PEtOXA 
and PCL, which is also a possible way to enhance the overall performance of ABPs as 
the gene delivery nanocarriers.  
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6. Experimental part 
6.1. Materials 
2-Mercaptoethanol (≥99%, Aldrich), 2-(Boc-amino)ethanethiol (97%, Aldrich), 2-methyl-2-
oxazoline (98%, Aldrich), ), 2-ethyl-2-oxazoline (≥99%, Aldrich), Tin(II) 2-ethylhexanoate 
(92.5-100.0%, Aldrich), triethylamine (≥99%, Aldrich), phenyl disulfide (99%, Aldrich), 
succinic anhydride (≥99%, Aldrich), trifluoromethanesulfonic anhydride (≥99%, Aldrich), 
hexamethylcyclotrisiloxane (D3) (98%, Aldrich), calcium hydroxide (95%, Aldrich), 
platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane complex (Pt(dvs)) solution in xylene (Pt 
~2 %, Aldrich), 2-allyloxyethanol (98%, Aldrich), ε-benzyloxycarbonyl-L-lysine ((≥99%, Aldrich), 
chlorodimethylsilane (98%, Aldrich), n-butyllithium solution (2.5 M in cyclohexane, Aldrich), 
activated carbon (Fluka), molecular sieve 4 Å (Chemie Uetikon AG, Switzerland), 5-
doxylstearic acid (5-DSA) and 16-doxylstearic acid (16-DSA), N,N-Diisopropylethylamine 
(99.5%, Aldrich), methyl trifluoromethanesulfonate (≥ 98%, Sigma), ε-caprolactone (≥ 99%, 
Sigma), potassium thioacetate (98%, Sigma), triphenylphosphine ( 99%, Sigma), Tin(II) 2-
ethylhexanoate (~95%, Sigma), Pd/C (10 wt. %, Sigma), 2-pyridylthio cysteamine 
hydrochloride (≥ 97%, Activate Scientific), N,N'-dicyclohexylcarbodiimide (99%, sigma), 4-
dimethylaminopyridine (≥ 99%, sigma), Dox.HCl (98%, Beijing Zhongshuo Pharmaceutical 
Technology Development Co., Ltd.), trifluoroacetic acid (99%, Sigma), acetic acid (≥ 99.8%, 
Fluka), hydrobromic acid solution (33 wt. % in acetic acid, Sigma), anhydrous meOH (≥99.5%, 
Sigma), anhydrous DMF (99.8%, Sigma), anhydrous EtOH (≥99.5%, Sigma), diethyl ether 
(≥99.9%, Sigma), ethyl acetate (≥99.8%, Sigma), dichloromethane (≥99.9%, Sigma), toluene 
(≥99.9%, Sigma), PBS buffer (pH=7.2, life technologies). Dichloromethane, acetonitrile, 
toluene, triethylamine and chloroform with 100-200 ppm amylenes as stabilizers were 
freshly refluxed with calcium hydroxide under argon. Tetrahydrofuran (THF) and 
cyclohexane were refluxed with sodium and benzophenone under argon. Triton X-100 (Fluka) 
was used as a 1% solution in distilled water. Other chemicals and solvents were used directly 
without any purification. 
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6.2. Copolymer synthesis procedures 
6.2.1. Synthesis of PDMS-b-PMOXA diblock copolymer  
Monocarbinol Poly(dimethylsiloxane) (PDMS-OH). Fresh dried hexamethylcyclotrisiloxane 
(D3) (69.12 g, 310.71 mmol) was distilled into a dried three necks round flask under vacuum. 
Fresh dried and distilled cyclohexane (110 mL) and n-buty lithium solution (9.52 mL, 23.91 
mmol) were added successively at the room temperature under argon atmosphere. After 4.5 
hours, fresh dried and distilled THF (12 mL) was added under argon atmosphere. After 40 
hours, dimethylchlorosilane (8.5 mL, 76.57 mmol) was added to quench the reaction. The 
white LiCl salt was filtrated in 4 hours, and then the solvent and unreacted D3 were distilled 
under high pressure in order to yield the 1.  1 (5.2 g, 2 mmol) was dissolved in fresh distilled 
toluene first, then 2-allyloxyethanol (0.25g, 2.1 mmol) and Pt(dvs) (2.28 µL) were added 
successively. The mixture was stirred overnight at 110 °C under inert atmosphere. After 
removal of the toluene, dichloromethane and the activated carbon were added and the final 
product was filtrated to yield the PDMS-OH as colorless oil. 1H NMR (400 MHz, δ, CDCl3): 0 
ppm (m, -Si(CH3)2), 0.54 ppm (m, -SiCH2), 0.88 ppm (t, -CH3), 1.31 (m, -CH2-CH2-), 1.62 (m, -
SiCH2-CH2-CH2O-), 3.44 ppm (t, -CH2-O- ), 3.54 ppm (t, -O-CH2-), 3.72 ppm (t, -CH2-OH). 
PDMS-OTf and PDMS-b-PMOXA. PDMS-OH (10.71g, 2.142 mmol) was put into a three-neck, 
round-bottomed flask and dried under stirring over night at 120 °C in high vacuum. Dry 
toluene was added under argon atmosphere and the solution was dried for 24 hours by 
reflux in a Soxleth apparatus containing a molecular sieve 4 Å. After cooling to room 
temperature, fresh dried and distilled triethylamine was added. The solution was cooled to 
0 °C and trifluoromethanesulfonic anhydride in 20 mL of dry toluene was added slowly over 
30 minutes. The mixture was reacted for another 3 hours at 0 °C. Then the mixture was 
separated from triflate salt by filtration through a glass frit. After evaporating the toluene, 
fresh dried and distilled chloroform (65 mL), acetonitrile (28 mL) and 2-methyl-2-oxazoline 
(4.19 g, 49.27 mmol) were added successively. The reaction mixture was stirred for 60 h at 
40 °C. Finally, the solution was cooled to room temperature, triethylamine (20 mL) and H2O 
(20 mL) were added to quench the reaction. The polymer was dissolved in ethanol, 
subsequently the ethanol solution was transferred into a solvent-resistant, stirred 
ultrafiltration device (Millipore, USA) equipped with a 3000 MWCO regenerated cellulose 
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membrane (Millipore, USA) and extensively washed with ethanol and H2O mixture for six 
times to yield transparent, rubber-like PDMS-b-PMOXA-OH diblock copolymer.  
PDMS-OTf: 1H NMR (400 MHz, δ, CDCl3): 0 ppm (m, -Si(CH3)2), 0.54 ppm (m, -SiCH2), 0.88 
ppm (t, -CH3), 1.31 (m, CH3-CH2-CH2-), 1.62 (m, -Si-CH2-CH2-CH2-O-), 3.45 ppm (t, -CH2-O- ), 
3.75 ppm (t, -O-CH2-), 4.62 ppm (t, -CH2-OTrf).  
PDMS-b-PMOXA: 1H NMR (400 MHz, δ, CDCl3): 0 ppm (m, -Si(CH3)2), 0.54 ppm (m, -SiCH2), 
0.88 ppm (t, -CH3), 1.31 ppm (m, -CH2-CH2-), 1.62 ppm (m, -SiCH2-CH2-CH2O-), 2.08-2.21 ppm 
(m, CH3-C=O), 3.40-3.60 ppm (m, -CH2-O-CH2-CH2-N-CH2-CH2-), 3.75 ppm (t, -CH2-OH).  
6.2.2. PMOXA-graft(ss)-PCL copolymer synthesis 
6.2.2. Synthesis of PMOXA-graft(ss)-PCL graft copolymer 
Poly(2-methyl-2-oxazoline) thioacetate (PMOXA-SAc). Methyl trifluoromethanesulfonate 
(120 mg, 0.73 mmol) and 2-methyl-2-oxazoline (5 g, 58.8 mmol) were dissolved in distilled 
acetonitrile (30 mL) and the polymerization was carried out at 80 °C for 18 h under argon 
atmosphere. The polymerization was terminated by the addition of potassium thioacetate 
(0.6 g, 3.74 mmol) at RT and the mixture was further stirred for another 24 h under argon. 
The excess of potassium thioacetate was filtered away and the produc,t PMOXA-SAc, was 
purified by precipitation in cold diethyl ether. The obtained precipitatant was dissolved in 
ddH2O and dialyzed against ddH2O for another 48 h to yield 4.6 g colorless PMOXA-SAc with 
a yield of 92%. 1H NMR (d6-DMSO): δ = 1.98 ppm (CH3-(C=O)), 2.34-2.37 ppm (S(O=C)-CH3), 
2.94 ppm (-CH2-S-), 2.99 ppm (CH3-N-), 3.35-3.47 ppm (-CH2-CH2-N).  
 
Thiolated poly(2-methyl-2-oxazoline) (PMOXA-SH). PMOXA-SAc (200 mg, 0.03 mmol) was 
dissolved in anhydrous MeOH (10 mL), and triphenylphosphine (56 mg, 0.22 mmol) was 
added. The solution was stirred for another 48 h at RT under argon atmosphere. Afterwards, 
the reaction mixture was precipitated twice in cold diethyl ether, and 170 mg of light pink 
PMOXA-SH was obtained with a yield of 85%. 1H NMR (d6-DMSO): δ = 1.98 ppm (CH3-(C=O)), 
2.94 ppm (-CH2-S-), 2.99 ppm (CH3-N-), 3.34-3.74 ppm (-CH2-CH2-N).  
Poly(ε-caprolactone)-co-poly(α-benzyl carboxylate-ε-caprolactone) (PCL-co-PBCL). 
Anhydrous EtOH (20.5 µL) was mixed with freshly distilled toluene (25 mL), followed by 
addition of ε-caprolactone (4.12 g, 36.1 mmol) and α-benzyl carboxylate-ε-caprolactone 
(0.85 g, 3.4 mmol) which was synthesized according to previously published procedure.199 
Subsequently, Tin(II) 2-ethylhexanoate (4 µL) was added to the above reaction mixture. 
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Finally, the reaction was carried out at 110 °C under argon atmosphere for 24 h. After the 
polymerization, the polymer was precipitated twice in diethyl ether to obtain 4.1 g of 
colorless poly(ε-caprolactone)-co-poly(α-benzyl carboxylate-ε-caprolactone) (PCL-co-PBCL) 
with a yield of 82%. 1H NMR (CDCl3): δ = 1.19 ppm (CH3-CH2-O-), 1.31 ppm ((C=O)-CH2-CH2-
CH2-CH2-CH2-O-), 1.56 ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-), 1.87 ppm (C6H6-CH2-(COO)-CH-
CH2-), 2.22 ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-), 3.33 ppm (C6H6-CH2-(COO)-CH-CH2-), 3.97 
ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-), 5.23 ppm (C6H6-CH2-), 7.26 ppm (C6H6-CH2-).  
Poly(ε-caprolactone)-co-poly(α-carboxylic acid-ε-caprolactone) (PCL-co-PCCL). PCL-co-PBCL 
(2 g, 0.11 mmol) was first dissolved in deoxygenated ethyl acetate (20 mL), and then Pd/C 
(600 mg) was added. Finally, the solution was stirred for 42 h at RT under hydrogen 
atmosphere. After the reaction was complete, the sample was centrifuged in order to 
remove the catalyst Pd/C, and was precipitated twice in cold diethyl ether to purify the 
polymer. 1.70 g of colorless PCL-b-PCCL was obtained with a yield of 85%. 1H NMR (CDCl3): δ 
= 1.27 ppm (CH3-CH2-O-), 1.41 ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-), 1.67 ppm ((C=O)-CH2-
CH2-CH2-CH2-CH2-O-), 1.95 ppm (HOOC-CH-CH2-), 2.34 ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-), 
3.37 ppm (HOOC-CH-CH2-), 4.07 ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-).  
Poly(ε-caprolactone)-co-poly(α-pyridyldisulfide-ε-caprolactone) (PCL-co-PPCL). PCL-co-
PCCL (500 mg, 0.028 mmol), 2-pyridylthiol cysteamine hydrochloride (60 mg, 0.27 mmol) and 
triethylamine (104 µL) were dissolved in freshly distilled dichloromethane (20 mL), and then 
N,N'-dicyclohexylcarbodiimide (100 mg, 0.48 mmol) and 4-dimethylaminopyridine (10 mg, 
0.082 mmol) were added. The reaction was carried out at RT under argon atmosphere for 60 
h. The mixture was precipitated in cold diethyl ether twice, yielding 300 mg of colorless PCL-
co-PPCL with a yield of 60%. 1H NMR (CDCl3): δ = 1.26 ppm (CH3-CH2-O-), 1.34 ppm ((C=O)-
CH2-CH2-CH2-CH2-CH2-O-), 1.65 ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-), 1.98 ppm (-NH-(C=O)-
CH-CH2-), 2.30 ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-), 2.93 ppm (-SS-CH2-CH2-), 3.54 ppm (-
NH-(C=O)-CH-CH2-), 3.65 ppm (-SS-CH2-CH2-), 4.05 ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-), 
7.0-8.6 ppm (-SS-C6H4N).  
Poly(2-methyl-2-oxazoline)-graft(ss)-poly(ε-caprolactone) (PMOXA-graft(ss)-PCL). PCL-co-
PPCL (120 mg, 0.0067 mmol) and PMOXA-SH (290 mg, 0.038 mmol) were dissolved in 
dimethylformamide (10 mL), and acetic acid (200 µL) was added all at once. The solution was 
stirred at RT under argon atmosphere for 72 h. The copolymer was purified by precipitation 
in cold MeOH and produced 100 mg of a white solid product with a yield of 38%. 1H NMR 
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(CDCl3): δ = 1.26 ppm (CH3-CH2-O-), 1.38 ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-), 1.64 ppm 
((C=O)-CH2-CH2-CH2-CH2-CH2-O-), 2.11 ppm (-(C=O)-CH3), 2.30 ppm ((C=O)-CH2-CH2-CH2-CH2-
CH2-O-), 2.84 ppm (-CH2-SS-CH2-), 3.05 ppm (CH3-N(C=O)-), 3.46 ppm (-N-CH2-CH2-N-), 4.06 
ppm ((C=O)-CH2-CH2-CH2-CH2-CH2-O-). 
6.2.3. Synthesis of PEtOXA-PCL-ss-PLL amphiphilic triblock copolymer 
Tert-butyl N-(2[(2-hydroxyethyl)disulfanyl]ethyl)carbamate. 2-(2-(pyridin-2-
yl)disulfanyl)ethanol was synthesized according to the method previously published.214 2-(2-
(pyridin-2-yl)disulfanyl)ethanol (0.6 g, 3.2 mmol) was first dissolved in a mixture of MeOH (8 
mL) and DCM (8 mL). Then N-(tert-butoxycarbonyl)-2-aminoethanethiol (1.62 mL, 9.6 mmol) 
was added and the reaction mixture was deoxygenated by vacuum argon cycles, the reaction 
was carried out at RT for 20 h under argon. The reaction was quenched by adding 0.05 g/mL 
I2/MeOH and a color change from colorless to brown was observed. For purification, the 
reaction mixture was washed with brine twice, and the organic phase was collected and 
dried with Na2SO4. Finally, the product was purified by column chromatography with silica as 
the solid phase using a mixture of hexane and ethyl acetate (V/V = 2/1) as the running phase. 
0.7 g colorless oil product was obtained with a yield of 87.5%. 1H NMR (CDCl3): δ = 4.97 ppm 
(br, 1H), 3.89 ppm (t, 2H), 3.46 ppm (q, 2H), 2.88 ppm (t, 2H), 2.81 ppm (t, 2H), 1.45 ppm (s, 
2H). 13C NMR (CDCl3): δ = 156 ppm, 80 ppm, 60 ppm, 42 ppm, 39 ppm, 38 ppm, 28 ppm.  
Poly(2-ethyl-2-oxazoline)-OH. Methyl trifluoromethanesulfonate (109 µL, 0.99 mmol) was 
dissolved in anhydrous acetonitrile (100 ml), and then 2-ethyl-2-oxazoline (10 mL) was 
added. After deoxygenating, the polymerization was initiated and further carried out at 
80 °C for 24 h under argon. After polymerization, the reaction mixture was cooled down to 
RT and a KOH/MeOH solution (0.5 M) (10 mL) was added in order to quench the reaction. 9 g 
of a colorless solid polymer was obtained by precipitation from diethyl ether with a yield of 
90%. 1H NMR (CDCl3): δ = 3.45 ppm (br, N-CH2-CH2-), 2.2-2.41 ppm (br, O=C(N)-CH2-CH3), 
1.12 ppm (O=C(N)-CH2-CH3).   
Poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone)-OH. Lyophilized PEtOXA-OH (3.18 g) 
was first mixed with freshly distilled ε-caprolactone (4.53 mL, 41.2 mmol), then, freshly 
distilled toluene (80 °C) (200 mL) was added to dissolve the PEtOXA-OH and ε-caprolactone. 
Finally, stannous octoate (30 µL, 0.09 mmol) was added to the polymerization medium. After 
deoxygenation, the polymerization was carried out at 110 °C for 24 h under argon. 6 g of a 
colorless solid was obtained by precipitation from diethyl ether twice in a 78% yield. 1H NMR 
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(CDCl3): δ = 4.06 ppm (t, CH2-(O) C=O), 3.65 ppm (t, CH2-OH), 3.45 ppm (br, N-CH2-CH2-), 2.2.-
2.41 ppm (br, O=C(N)-CH2-CH3), 2.31 ppm (t, O=C(O)-CH2-CH2-CH2-CH2-), 1.66 ppm (br, 
O=C(O)-CH2-CH2-CH2-CH2-), 1.38 ppm (m, OC(O)-CH2-CH2-CH2-CH2-), 1.12 ppm (O=C(N)-CH2-
CH3).   
Poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone)-COOH (PEtOXA-b-PCL-COOH). 
PEtOXA-b-PCL-OH (2 g) was first dissolved in anhydrous chloroform (25 mL). Then succinic 
anhydride (84 mg, 0.84 mmol), triethylamine (150 µL, 1.08 mmol) and DMAP (6 mg, 0.05 
mmol) were added. After deoxygenation, the reaction was carried out at RT for 72 h under 
argon. Finally, 1.82 g of polymer was obtained by precipitation in diethyl ether with a yield of 
91%. 1H NMR (CDCl3): δ = 4.06 ppm (t, CH2-(O)C=O), 3.46 ppm (br, N-CH2-CH2-), 2.63 ppm (-
CH2-CH2-COOH), 2.2.-2.41 ppm (br, O=C(N)-CH2-CH3), 2.33 ppm (t, O=C(O)-CH2-CH2-CH2-CH2-), 
1.66 ppm (br, O=C(O)-CH2-CH2-CH2-CH2-), 1.38 ppm (m, O=C(O)-CH2-CH2-CH2-CH2-), 1.12 ppm 
(O=C(N)-CH2-CH3).   
Poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone)-ss-NHBoc (PEtOXA-b-PCL-ss-NHBoc). 
PEtOXA-b-PCL-COOH (1.05 g) was first dissolved in anhydrous chloroform. Then, tert-butyl N-
(2[(2-hydroxyethyl)disulfanyl]ethyl)carbamate (85 mg, 0.34 mmol), DCC (130 mg, 0.63 mmol) 
and DMAP (2 mg, 0.016 mmol) were added. After deoxygenation, the reaction was carried 
out at RT for 72 h under argon. Finally, 865 mg PEtOXA-b-PCL-ss-NHBoc was obtained by 
precipitation in diethyl ether with a yield of 86.5%. 1H NMR (CDCl3): δ = 4.04 ppm (t, CH2-
(O)C=O), 3.45 ppm (br, N-CH2-CH2-), 2.91 ppm (-CH2-SS-CH2-), 2.64 ppm (O=C(O)-CH2-CH2-
(O)C=O), 2.2.-2.41 ppm (br, O=C(N)-CH2-CH3), 2.31 ppm (t, O=C(O)-CH2-CH2-CH2-CH2-), 1.66 
ppm (br, O=C(O)-CH2-CH2-CH2-CH2-), 1.44 ppm (s, (CH3)-C-), 1.38 ppm (m, O=C(O)-CH2-CH2-
CH2-CH2-), 1.12 ppm (O=C(N)-CH2-CH3). 
Poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone)-ss-NH2.TFA (PEtOXA-b-PCL-ss-
NH2.TFA). PEtOXA-b-PCL-ss-NHBoc was dissolved in TFA (10 mL), and then the solution was 
stirred for 1.5 h at 0 °C. 821 mg of a colorless solid was obtained by precipitation from 
diethyl ether with a yield of 95%. 1H NMR (CDCl3): δ = 4.36 ppm (t, NH2-CH2-), 4.04 ppm (t, 
CH2-(O)C=O), 3.45 ppm (br, N-CH2-CH2-), 2.94, 3.03 ppm (-CH2-SS-CH2-), 2.64 ppm (O=C(O)-
CH2-CH2-(O)C=O), 2.2-2.41 ppm (br, O=C(N)-CH2-CH3), 2.31 ppm (t, O=C(O)-CH2-CH2-CH2-CH2), 
1.66 ppm (br, O=C(O)-CH2-CH2-CH2-CH2-), 1.38 ppm (m, O=C(O)-CH2-CH2-CH2-CH2-), 1.12 ppm 
(O=C(N)-CH2-CH3).  
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Poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone)-ss-poly(ε-benzyloxycarbonyl-L-lysine) 
(PEtOXA-b-PCL-ss-PzLL). PEtOXA-b-PCL-ss-NH2.TFA (98 mg) was first dissolved in anhydrous 
DMF (4.5 mL). Then DIPEA (10 µL) and ε-benzyloxycarbonyl-L-lysine N-carboxyanhydride 
(138 mg ) were added.215 After deoxygenation, the reaction was carried out at RT for 72 h 
under argon. 180 mg of a colorless solid was obtained by precipitation in diethyl ether with a 
yield of 83%. 1H NMR (CDCl3): δ = 8.24 ppm (br, NH-C=O), 7.26 ppm (m, -C6H5), 4.99 ppm (br, 
C6H5-CH2-), 4.06 ppm (t, CH2-(O)C=O), 3.46 ppm (br, N-CH2-CH2-), 3.10 ppm (br, C6H5-CH2-O-
C(=O)-NH2-CH2-), 2.86 ppm (-CH2-SS-CH2-), 2.58 ppm (O=C(O)-CH2-CH2-(O)C=O), 2.2-2.43 ppm 
(br, O=C(N)-CH2-CH3), 2.31 ppm (t, O=C(O)-CH2-CH2-CH2-CH2-), 1.39-1.88 ppm (br, NH-C(=O)-
CH-CH2-CH2-CH2-), 1.63 ppm (br, O=C(O)-CH2-CH2-CH2-CH2-), 1.39 ppm (m, O=C(O)-CH2-CH2-
CH2-CH2-), 1.12 ppm (m, O=C(N)-CH2-CH3).  
Poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone)-ss-poly(L-lysine) (PEtOXA-b-PCL-ss-
PLL). PEtOXA-b-PCL-ss-PzLL (240 mg) was dissolved in TFA (15 mL), then a HBr in acetic acid 
solution (33%) (5mL) was added drop wise at 0 °C. The solution was further stirred for 
another 1 h at 0 °C. The product was precipitated in diethyl ether and then dissolved in 
DMSO. The DMSO solution was dialyzed against ddH2O for 48 h, changing the ddH2O three 
times. After lyophilizing, a white powder (180 mg) was obtained with a yield of 85%. 1H NMR 
(d6-DMSO): 4.25 ppm (br, NH-(C=O)-CH-), 4 ppm (m, CH2-O-C=O), 3.45 ppm (br, N-CH2-CH2-), 
2.96 ppm (m, -CH2-SS-CH2-), 2.75 ppm (-CH2-NH2), 2.26 ppm (br, O=C(N)-CH2-CH3 and -O-
(C=O)-CH2-CH2-CH2-CH2-), 1.30-1.54 ppm (-O-(C=O)-CH2-CH2-CH2-CH2- and –CH2-CH2-CH2-
CH2-NH2), 0.95 ppm (m, O=C(N)-CH2-CH3). 
6.2.4. Synthesis of PEtOXA-ss-PLL and PEtOXA-PLL control copolymers. 
Poly(2-ethyl-2-oxazoline) disulfide amine (PEtOXA-ss-NH2). PEtOXA-SAc and PEtOXA-ss-Py 
were synthesized according to the method described in the literature.198 PEtOXA-ss-Py (1 g) 
was first dissolved in MeOH (20 mL), and then cysteamine (279 mg, 3.62 mmol) was added. 
After deoxygenation, the reaction was carried out at RT for 48 h under argon. Finally, 0.96 g 
of a colorless solid polymer was obtained by precipitation in diethyl ether twice with a yield 
of 96%. 1H NMR (CDCl3): δ = 4.16 ppm (s, -CH2-NH2), 3.45 ppm (br, N-CH2-CH2-), 3.03 ppm 
(CH3-CH2-CH2-), 2.84 ppm (-CH2-SS-CH2-), 2.31-2.41 ppm (br, O=C(N)-CH2-CH3), 1.12 ppm 
(O=C(N)-CH2-CH3).  
Poly(2-ethyl-2-oxazoline)-ss-poly(ε-benzyloxycarbonyl-L-lysine) (PEtOXA-ss-PzLL). PEtOXA-
ss-NH2 (102 mg) was first dissolved in anhydrous DMF (3 mL), and then ε-benzyloxycarbonyl-
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L-lysine N-carboxyanhydride (205 mg, 0.67 mmol) was added. After deoxygenation, the 
polymerization was carried out at RT for 48 h under argon. 253 mg of a colorless polymer 
was obtained by precipitation from diethyl ether with a yield of 82.4%. 1H NMR (CDCl3): δ = 
8.22 ppm (br, NH-C=O), 7.23 ppm (m, -C6H5), 5.47 ppm (br, O=C-NH-), 4.99 ppm (br, C6H5-
CH2-), 3.45 ppm (br, N-CH2-CH2-), 3.10 ppm (br, C6H5-CH2-O-C(=O)-NH2-CH2-), 2.86 ppm (-
CH2-SS-CH2-), 2.29.-2.41 ppm (br, O=C(N)-CH2-CH3), 1.26-2.10 ppm (br, NH-C(=O)-CH-CH2-
CH2-CH2-), 1.12 ppm (O=C(N)-CH2-CH3). 
Poly(2-ethyl-2-oxazoline)-ss-poly(L-lysine) (PEtOXA-ss-PLL). PEtOXA-ss-PzLL (419 mg) was 
dissolved in TFA (15 mL), then HBr in acetic acid solution (33%) (4 mL) at 0 °C was added 
dropwise. The solution was stirred for another 1 h at 0 °C. The product was precipitated in 
diethyl ether and then dissolved in DMSO. The DMSO solution was further dialyzed against 
ddH2O for 48 h changing ddH2O three times. After lyophilizing, a white powder (300 mg) was 
obtained with a yield of 80%. 1H NMR (D2O): δ = 4.24 ppm (t, NH-C(=O)-CH-), 3.27-3.64 ppm 
(br, N-CH2-CH2-), 2.93 ppm (t, NH2-CH2-), 2.27 ppm (m, O=C(N)-CH2-CH3), 1.25-1.82 ppm 
(NH2-CH2-CH2-CH2-CH2-), 0.97 ppm (m, O=C(N)-CH2-CH3).  
Poly(2-ethyl-2-oxazoline)-block-poly(ε-benzyloxycarbonyl-L-lysine) (PEtOXA-b-PzLL). 
PEtOXA-NH2 (150 mg) was synthesized according with the previously published procedure,216 
was dissolved in anhydrous DMF (10 mL), and further ε-benzyloxycarbonyl-L-lysine N-
carboxyanhydride (126 mg, 0.41 mmol) was added in the solution mixture After 
deoxygenation, the reaction was carried out at RT for 50 h under argon. Finally, 242 mg 
colorless polymer was obtained after precipitation in diethyl ether twice with a yield of 94%. 
1H NMR (CDCl3): δ = 8.21 ppm (br, NH-C=O), 7.23 ppm (m, -C6H5), 5.46 ppm (br, O=C-NH-), 
4.99 ppm (br, C6H5-CH2-), 3.45 ppm (br, N-CH2-CH2-), 3.10 ppm (br, C6H5-CH2-O-C(=O)-NH2-
CH2-), 2.20-2.48 ppm (br, O=C(N)-CH2-CH3), 1.26-2.08 ppm (br, NH-C(=O)-CH-CH2-CH2-CH2-), 
1.12 ppm (O=C(N)-CH2-CH3).  
Poly(2-ethyl-2-oxazoline)-block-poly(L-lysine) (PEtOXA-b-PLL). PEtOXA-b-PzLL (355.7 mg) 
was dissolved in TFA (17 mL), then HBr in acetic acid solution (33%) (4 mL) at 0 °C was added 
dropwise. The solution was stirred for another 1 h at 0 °C. The product was purified by 
precipitation in diethyl ether and then dissolved in DMSO. The DMSO solution was then 
dialyzed against ddH2O for 48 h changing ddH2O three times. After lyophilizing, 240 mg 
white powder was obtained with a yield of 68%. 1H NMR (D2O): δ = 4.26 ppm (t, NH-C(=O)-
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CH-), 3.32-3.60 ppm (br, N-CH2-CH2-), 2.96 ppm (t, NH2-CH2-), 2.29 ppm (m, O=C(N)-CH2-CH3), 
1.22-1.78 ppm (NH2-CH2-CH2-CH2-CH2-), 0.97 ppm (m, O=C(N)-CH2-CH3).  
 
6.3. Characterization techniques 
1H NMR spectra were recorded on a Bruker DPX-400 MHz spectrometer in CDCl3 without 
tetramethysilane standard, CDCl3 with tetramethysilane standard, d6-DMSO and D2O, and 
analyzed using MestReNova software.  
The molecular weight and PDIs of polymers were determined using a Viscotek GPC max 
system equipped with four Agilent PL gel columns (10μm guard; mixed C; 10 μm, 100 Å; 5 
μm, 103 Å). THF and DMF were used as eluent at a flow rate of 1 mL min−1 at 40 °C. Signals 
were recorded with a refractive-index detector and calibrated against polystyrene standards 
(Agilent). 
Transmission electron microscopy (TEM) was used to analyze the supramolecular assemblies 
of block copolymers. Sample solutions were negatively stained with 2% uranyl acetate 
solution and deposited on a carbon-coated copper grid. The samples were examined on a 
Philips Morgagni 268D TEM operated at 80 kV. Particle sizes were calculated from TEM 
images by averaging the diameters (mean ± S.D.) from at least 50 particles.  
Cryo-electron microscopy was used to visualize the self-assembled structures in their native 
environment. Polymer suspensions in buffer (20 mM Hepes, pH 7.4, 50 mM NaCl) at 
concentrations of 5 mg/mL were deposited on glow-discharged holey carbon grids 
(Quantufoil, Germany) and blotted before quick-freezing in liquid ethane by using a Vitrobot 
plunging freezing device (FEI company, USA). The grids were stored in liquid nitrogen before 
transferring them to a cryo-holder (Gatan, USA). ). Imaging was performed with a Philips 
CM200 FEG TEM at an accelerating voltage of 200 kV in low-dose mode with a defocus of -6 
µm for imaging and a defocus of -3 µm for membrane thickness determination. Membrane 
thicknesses represent a mean value of at least 150 single distance measurements along the 
membrane thickness of five different images.217 
Light scattering (LS) was used to characterize the assembled structures in solution. Dynamic 
light scattering (DLS) and static light scattering (SLS) experiments were performed on an ALV 
goniometer (ALV GmbH, Germany), equipped with an ALV He-Ne laser (λ = 632.8 nm). Light 
scattering measurements were performed in 10 mm cylindrical quartz cells at angles of 30 – 
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150° at 293 K. The obtained data were processed using ALV static & dynamic fit and plot 
software (version 4.31 10/01). SLS data were processed according to the Guinier-model, and 
DLS data by using a Williams-Watts function. 
The critical micelle concentration (CMC) was determined for the PDMS65-b-PMOXA14 and 
PDMS65-b-PMOXA32 by surface tension with concentration from 3*10-4 to 1*10-2. Surface 
tension was measured on a Sigma 703D (KSV Inst.) tensiometer with a platinum wilhelmy 
plate precleaned with isopropyl alcohol and water, followed by flame annealing. Solution 
was prepared 24 h prior to measurement by diluting the stock solution to different 
concentration. The CMC values were calculated from the interception point of the two 
tangent straight lines. 
The critical micelles concentration (CMC) values of three PMOXA-graft(SS)-PCL samples were 
determined by using pyrene as the fluorescence probe. The concentration of graft 
copolymers was varied from 1*10-5 mg/mL to 0.5 mg/mL, while preserving the same 
concentration of pyrene at 0.8 µM. After mixing the graft copolymer solution with pyrene, 
the solution was kept in the dark at 37 °C for 12 h before measuring. Fluorescence spectra 
were recorded using fluorescence spectroscopy at an excitation wavelength of 330 nm. 
Fluorescence emission at 372 and 383 nm were monitored. The CMC was estimated as the 
cross-point when extrapolating the intensity ratio I383 / I372 at low and high concentration 
regions.  
Small angle X-ray scattering (SAXS) was performed on a Bruker AXS Nanostar with an 
Incoatec Cu - IμS Microfocus X-ray source (λ = 0.154 nm) and a virtually noise-free, real-time 
2D Hi-Star detector with photon counting ability. The measurements were done with 45 kV 
and 650 µA and the integration time was 9 h. About 20 μl of sample with the concentration 
of 5 mg⋅ml-1 was loaded into a glass capillary (d = 1 mm, thickness of the wall = 0.01 mm). 
The closed capillary set up into the Nanostar, vacuum was applied and the measurement 
was started. The data were azimuthally averaged with SAXS v.4.1.36 Bruker software and 
fitted with Nanofit.  
Electron paramagnetic resonance (EPR) measurements were performed on a Bruker CW EPR 
Elexsys-500 spectrometer equipped with a variable temperature unit. The spectra were 
recorded at temperatures varying between 150 and 320 K with the following parameters: 
100 KHz magnetic field modulation, microwave power 2 mW, number of scans up to 20, 
modulation amplitude in the range of 0.4 G. The nitrogen hyperfine coupling (aN) was 
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determined directly from the spectra for motionally narrowed lineshapes with an error limit 
of 5%. 2aN values correspond to the distance (in gauss) between the low-field and high-field 
lines of the motionally averaged spectra (triplets) recorded at temperatures above 270 K, 
whereas 2Azz values are measured as a distance between the last minimum and the first 
maximum (extreme separation) in the rigid limit spectra recorded from frozen solutions. The 
microviscosity in the proximity of the nitroxide free-radical probe was determined from the 
correlation time τc, which is related to the rate of rotational reorientation of the probe: 
𝜏𝑐 = 6.5𝑒−10 ∗ ∆𝐻0 ∗ �� 𝐼0𝐼+1 + � 𝐼0𝐼−1 − 2� 
where ΔH0 is the linewidth of the mI = 0 transition, and I0, I+1, I-1 are the peak to peak 
heights of the mI = 0, +1 and -1 transitions, respectively.160 
Fourier transform infrared spectroscopy (FTIR) (PerkinElmer Spectrum 100 FTIR 
Spectrometer) was used to characterize the presence of specific chemical groups. Polymer 
samples were measured with 256 scans and 2 cm-1 resolution. The spectra were measured 
from 400 to 4000 cm-1. 
The particle size was characterized by dynamic light scattering (DLS) at a fixed angle of θ = 
173o using a Zetasizer Nano (Malvern, Worcestershire, UK) with a laser beam wavelength of 
633 nm.  
Fluorescence emission spectroscopy was performed on a Perkin Elmer, LS55. 
Fluorescence correlation spectroscopy (FCS) and confocal laser scanning microscopy (CLSM) 
were performed on a commercial Zeiss LSM 510 META/ConfCor 2. For FCS, a HeNe laser (633 
nm), a 40x water-immersion objective (Zeiss C/Apochromat 63X, NA 1.2) and the 
appropriate filter sets were used. For CLSM, a laser diode (405 nm), argon laser (488 nm), 
helium/neon laser (633 nm) and a 63× water-immersion objective (Zeiss C/Apochromat 63X, 
NA 1.2) were used. The cells were imaged in multitrack mode, whereas the channel for 
Doxorubicin was fixed to the same settings over all images. The images were processed using 
LSM Image Browser (Zeiss). 
6.4. Reduction-triggered destabilization of PMOXA-graft(ss)-PCL 
nanoparticles 
The size of the nanoparticles in response to 10 mM DTT in PBS was traced by DLS 
measurements. Briefly, 1 mL of a PMOXA-graft(ss)-PCL nanoparticle solution (1 mg/mL) in 
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PBS was transferred into a DLS measurement cell, to which concentrated DTT PBS buffer 
solution was added to adjust the final concentration of DTT to 10 mM. At different time 
intervals, the size of the nanoparticles was measured by DLS. 
6.5. Reduction-triggered release of dye from nanoparticles formed by 
PMOXA-graft(ss)-PCL 
BODIPY 630-loaded PMOXA-graft(ss)-PCL nanoparticles were prepared as described above 
using 1 µM of dye-solution in PBS. Aliquots of 20 µl nanoparticle solution were added to 200 
µl pre-warmed (37 °C) PBS (controls) or 11 mM DTT in PBS and incubated under shaking (500 
RPM) at 37 °C in an Eppendorf Thermomixer Comfort. 5 µl of these mixtures were 
transferred for subsequent FCS measurements at each time point (20 x 5s FCS curves each). 
Resulting FCS curves were fitted with a two-component system, whereas one diffusion 
parameter was fixed to free dye diffusion (about 60 µs). FCS curves that could not be fitted 
correctly by the program were excluded from the average (less than 1% of all curves). 
Percentage of free dye is presented as average ± s.e.m. for three independent 
measurements using two independent samples for each copolymer. Hydrodynamic 
diameters (DH) were calculated using Einstein-Stokes equation; diffusion constants obtained 
for the nanoparticles and free Atto655 in PBS as a calibration for the confocal volume. DH for 
nanoparticles was only given when smaller than 350 nm (aggregates are represented with DH 
350 nm) and a particle fraction of at least 10%.  
6.6. Loading of anti-cancer drug DOX in nanoparticles formed by 
PMOXA-graft(ss)-PCL 
DOX-loaded PMOXA-graft(ss)-PCL nanoparticles were obtained by drop wise addition of 1 
mL PBS into the mixture 0.2 mL PMOXA-graft(ss)-PCL or PMOXA-b-PCL solution in DMF (5 
mg/mL) and 10 µl, 30 µl and 50 µl DOX in the solution DMSO (5 mg/mL) under stirring at RT, 
followed by dialysis against PBS with MWCO 3500 dialysis tube at RT in the dark with 
changing three times PBS buffer solution in 24 h. The amount of DOX was determined using 
fluorescence measurement with excitation at 480 nm and emission at 560 nm. For 
determination of the drug loading content, the samples were first lyophilized, then DOX 
loaded PMOXA-graft(SS)-PCL or PMOXA-b-PCL nanoparticles were dissolved in 1 mL 
DMSO/DMF mixture (VDMSO /VDMF = 2 : 1) and analyzed with fluorescence spectroscopy. The 
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DOX standard calibration curve in DMSO/DMF mixture solvent (VDMSO /VDMF = 2 : 1) was 
obtained also by fluorescence spectroscopy. 
Drug loading content (DLC) and drug loading efficiency (DLE) were calculated according to 
the following formulas: 
DLC (wt%) = (weight of loaded drug / weight of polymer) * 100% 
DLE (%) = (weight of loaded drug / weight in feed) * 100% 
6.7. Cell culture 
HeLa cells were grown in 75 cm2 cell culture flasks (BD Bioscience) at 37 °C under a 5% CO2 
atmosphere in the cell culture medium (normal cell grow conditions). When cells reached a 
confluency of about 80%, they were split in a 1 : 10 ratio. To prepare the cell culture medium 
50 ml fetal bovine serum (BioConcept AG), 10 ml 10’000 U/ml penicillin and 10’000 μg/ml 
streptomycin (Gibco) were filled up to 500 ml with fresh Dulbecco’s modified eagle’s 
medium (DMEM) (Sigma). The medium was sterile filtered through a 0.2 μm vacuum filter 
(Millipore). The cells were subcultured by trypsinization. 
6.8. Preparation for live cell imaging 
For live images 50’000 HeLa cells were seeded into each 8-well microscope chamber slides 
(Nunc) for 24 h in a normal cell culture conditions. Before adding the samples to the cells, 
old medium was removed; new medium was added to such an amount that in the end the 
total volume with sample resulted to be 100 μl. After 1 h, 2 h, 4 h or 8 h incubation under 
normal cell growing conditions cells were washed with PBS and 400 μl DMEM was added. To 
stain nucleus and cell membrane, cells were incubated with 0.2 μg/ml Hoechst 33342 
(Invitrogen) for 25 min and 2.5 μg/ml CellMask Deep Red (Invitrogen) for 5 min. 
Subsequently, cells were washed with PBS and wells were filled up with 400 μl PBS. 
6.9. MTS assay 
Into each vial of a 96-well plate (Falcon) 10’000 cells were seeded, filled up to 100 μl with 
cell culture medium and incubated for 24 h under normal cell grow conditions. Prior to 
addition of the sample, the old medium was removed, DOX loaded PMOXA-graft(ss)-PCL 
nanoparticles, DOX loaded PMOXA-b-PCL nanoparticles, free DOX or PBS were added to a 
volume of 20 μl and filled up to 100 μl with cell growing medium. The samples had a final 
DOX concentration of 0.9 µg/ml, 2.7 µg/ml, 4.5 µg/ml and 9 µg/ml, or blank PMOXA-
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graft(ss)-PCL nanoparticles. As a control, 20 μl PBS was added and filled up to 100 μl with cell 
growing medium and the blank measurement was prepared the same but without cells. The 
cells were then incubated for 48 h at normal cell growing conditions. Subsequently, 10 μl of 
MTS (Promega) was added to each well and incubated for another 4 h. The absorbance at 
490 nm was measured with a plate reader Spectramax M5e (Molecular Device). To calculate 
the cell viability the average value from the blank was subtracted from the measured 
samples values and normalized to the average of value only cells. Data are presented as 
average ± SD (n = 8). 
6.10. DNA complex with PEtOXA-PCL-ss-PLL and gel retardation assay 
Dissolved 2mg PEtOXA-PCL-ss-PLL in 100 μL DMSO, and then dropwised 500 μL PBS into 
DMSO with continually being stirred slowly. The solution was transferred into dialysis tube 
with 3.5 KDa cut-off to dialyze against PBS for two days with changing PBS solution for three 
times, and finally adjusted PEtOXA-PCL-ss-PLL final concentration to be 2 mg/mL. Mix pDNA 
with PEtOXA-PCL-ss-PLL solution together with N/P equaling to 7 to prepare DNA and 
PEtOXA-PCL-ss-PLL complexion solution. The mixture was kept at room temperature for 
another 30 minutes to make sure the complexion formation. For tracking a loading buffer 
(15% Ficoll 400 in TBE) containing bromophenol blue (0.1%) was added to each sample. All 
samples were loaded on a 0.8% agarose gel with 0.05 mg/mL ethidium bromide (EtBr) and 
electrophoresed with TBA buffer at 80 V for 45 min. Finally, the gel was imaged with a Gel 
Documentation System to visualize the pDNA migration.        
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